☰

Michael Platten - Publications

Affiliations: 
Hertie-Institute for Clinical Brain Research Eberhard Karls Universität Tübingen, Tübingen, Baden-Württemberg, Germany 
Tree Info Grants Similar researchers PubMed Report error

111/489 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Hunger J, Schregel K, Boztepe B, Agardy DA, Turco V, Karimian-Jazi K, Weidenfeld I, Streibel Y, Fischer M, Sturm V, Santarella-Mellwig R, Kilian M, Jähne K, Sahm K, Wick W, ... ... Platten M, et al. nanoparticle-based T cell imaging can predict therapy response towards adoptive T cell therapy in experimental glioma. Theranostics. 13: 5170-5182. PMID 37908732 DOI: 10.7150/thno.87248  0.671
2023 Grassl N, Poschke I, Lindner K, Bunse L, Mildenberger I, Boschert T, Jähne K, Green EW, Hülsmeyer I, Jünger S, Kessler T, Suwala AK, Eisele P, Breckwoldt MO, Vajkoczy P, ... ... Platten M, et al. A H3K27M-targeted vaccine in adults with diffuse midline glioma. Nature Medicine. 29: 2586-2592. PMID 37735561 DOI: 10.1038/s41591-023-02555-6  0.675
2023 Schregel K, Heinz L, Hunger J, Pan C, Bode J, Fischer M, Sturm V, Venkataramani V, Karimian-Jazi K, Agardy DA, Streibel Y, Zerelles R, Wick W, Heiland S, Bunse T, ... ... Platten M, et al. A cellular ground truth to develop MRI signatures in glioma models by correlative light sheet microscopy and atlas-based co-registration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 37429718 DOI: 10.1523/JNEUROSCI.1470-22.2023  0.696
2023 Turco V, Pfleiderer K, Hunger J, Horvat NK, Karimian-Jazi K, Schregel K, Fischer M, Brugnara G, Jähne K, Sturm V, Streibel Y, Nguyen D, Altamura S, Agardy DA, Soni SS, ... ... Platten M, et al. T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles. Nature Communications. 14: 771. PMID 36774352 DOI: 10.1038/s41467-023-36321-6  0.723
2022 Miller JJ, Gonzalez Castro LN, McBrayer S, Weller M, Cloughesy T, Portnow J, Andronesi O, Barnholtz-Sloan JS, Baumert BG, Berger MS, Bi WL, Bindra R, Cahill DP, Chang SM, Costello JF, ... ... Platten M, et al. Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions. Neuro-Oncology. PMID 36239925 DOI: 10.1093/neuonc/noac207  0.448
2022 Reinhardt A, Pfister K, Schrimpf D, Stichel D, Sahm F, Reuss DE, Capper D, Wefers AK, Ebrahimi A, Sill M, Felsberg J, Reifenberger G, Becker A, Prinz M, Staszewski O, ... ... Platten M, et al. Anaplastic ganglioglioma - a diagnosis comprising several distinct tumour types. Neuropathology and Applied Neurobiology. e12847. PMID 35977725 DOI: 10.1111/nan.12847  0.397
2021 Kilian M, Friedrich M, Sanghvi K, Green E, Pusch S, Kawauchi D, Löwer M, Sonner JK, Krämer C, Zaman J, Jung S, Breckwoldt MO, Willimksy G, Eichmüller SB, von Deimling A, ... ... Platten M, et al. T cell receptor therapy targeting mutant capicua transcriptional repressor in experimental gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34782365 DOI: 10.1158/1078-0432.CCR-21-1881  0.681
2021 Blobner J, Kilian M, Tan CL, Aslan K, Sanghvi K, Meyer J, Fischer M, Jähne K, Breckwoldt MO, Sahm F, von Deimling A, Bendszus M, Wick W, Platten M, Green E, et al. Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodes. Neuro-Oncology Advances. 3: vdab147. PMID 34738084 DOI: 10.1093/noajnl/vdab147  0.681
2021 Platten M, Bunse L, Wick A, Bunse T, Le Cornet L, Harting I, Sahm F, Sanghvi K, Tan CL, Poschke I, Green E, Justesen S, Behrens GA, Breckwoldt MO, Freitag A, et al. A vaccine targeting mutant IDH1 in newly diagnosed glioma. Nature. PMID 33762734 DOI: 10.1038/s41586-021-03363-z  0.675
2021 Koelsche C, Schrimpf D, Stichel D, Sill M, Sahm F, Reuss DE, Blattner M, Worst B, Heilig CE, Beck K, Horak P, Kreutzfeldt S, Paff E, Stark S, Johann P, ... ... Platten M, et al. Sarcoma classification by DNA methylation profiling. Nature Communications. 12: 498. PMID 33479225 DOI: 10.1038/s41467-020-20603-4  0.367
2020 Hahn A, Bode J, Alexander A, Karimian-Jazi K, Schregel K, Schwarz D, Sommerkamp AC, Krüwel T, Abdollahi A, Wick W, Platten M, Bendszus M, Tews B, Kurz FT, Breckwoldt MO. Large-scale characterization of the microvascular geometry in development and disease by tissue clearing and quantitative ultramicroscopy. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X20961854. PMID 33043767 DOI: 10.1177/0271678X20961854  0.658
2020 Kickingereder P, Brugnara G, Hansen MB, Nowosielski M, Pflüger I, Schell M, Isensee F, Foltyn M, Neuberger U, Kessler T, Sahm F, Wick A, Heiland S, Weller M, Platten M, et al. Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial. Radiology. 200978. PMID 32720870 DOI: 10.1148/Radiol.2020200978  0.374
2020 Grassl N, Bunse L, Beutel T, Klockziem M, Gass A, Platten M, Eisele P. Nivolumab for Treatment of Progressive Multifocal Leukoencephalopathy in Sézary Syndrome. European Journal of Neurology. PMID 32644207 DOI: 10.1111/Ene.14433  0.334
2020 Kudo T, Prentzell MT, Mohapatra SR, Sahm F, Zhao Z, Grummt I, Wick W, Opitz CA, Platten M, Green EW. Constitutive Expression of the Immunosuppressive Tryptophan Dioxygenase TDO2 in Glioblastoma Is Driven by the Transcription Factor C/EBPβ. Frontiers in Immunology. 11: 657. PMID 32477324 DOI: 10.3389/Fimmu.2020.00657  0.345
2020 Schell M, Pflüger I, Brugnara G, Isensee F, Neuberger U, Foltyn M, Kessler T, Sahm F, Wick A, Nowosielski M, Heiland S, Weller M, Platten M, Maier-Hein KH, von Deimling A, et al. Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trial. Neuro-Oncology. PMID 32393964 DOI: 10.1093/Neuonc/Noaa120  0.304
2020 Wen PY, Weller M, Lee EQ, Alexander BA, Barnholtz-Sloan JS, Barthel FP, Batchelor TT, Bindra RS, Chang SM, Chiocca EA, Cloughesy TF, DeGroot JF, Galanis E, Gilbert MR, Hegi ME, ... ... Platten M, et al. Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions. Neuro-Oncology. PMID 32328653 DOI: 10.1093/Neuonc/Noaa106  0.337
2020 Aslan K, Turco V, Blobner J, Sonner JK, Liuzzi AR, Núñez NG, De Feo D, Kickingereder P, Fischer M, Green E, Sadik A, Friedrich M, Sanghvi K, Kilian M, Cichon F, ... ... Platten M, et al. Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas. Nature Communications. 11: 931. PMID 32071302 DOI: 10.1038/S41467-020-14642-0  0.705
2020 Karimian-Jazi K, Münch P, Alexander A, Fischer M, Pfleiderer K, Piechutta M, Karreman MA, Solecki GM, Berghoff AS, Friedrich M, Deumelandt K, Kurz FT, Wick W, Heiland S, Bendszus M, ... ... Platten M, et al. Monitoring innate immune cell dynamics in the glioma microenvironment by magnetic resonance imaging and multiphoton microscopy (MR-MPM). Theranostics. 10: 1873-1883. PMID 32042342 DOI: 10.7150/thno.38659  0.69
2019 Opitz CA, Somarribas Patterson LF, Mohapatra SR, Dewi DL, Sadik A, Platten M, Trump S. The therapeutic potential of targeting tryptophan catabolism in cancer. British Journal of Cancer. PMID 31819194 DOI: 10.1038/S41416-019-0664-6  0.305
2019 Reinhardt A, Stichel D, Schrimpf D, Koelsche C, Wefers AK, Ebrahimi A, Sievers P, Huang K, Casalini MB, Fernández-Klett F, Suwala A, Weller M, Gramatzki D, Felsberg J, Reifenberger G, ... ... Platten M, et al. Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities. Acta Neuropathologica Communications. 7: 163. PMID 31661039 DOI: 10.1186/S40478-019-0801-8  0.655
2019 Shraibman B, Barnea E, Kadosh DM, Haimovich Y, Slobodin G, Rosner I, López-Larrea C, Hilf N, Kuttruff S, Song C, Britten C, Castle J, Kreiter S, Frenzel K, Tatagiba M, ... ... Platten M, et al. Withdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma. Molecular & Cellular Proteomics : McP. 18: 1270. PMID 31154440 DOI: 10.1074/Mcp.W119.001571  0.351
2019 Nowosielski M, Gorlia T, Bromberg JEC, Sahm F, Harting I, Kickingereder P, Brandes AA, Taphoorn MJB, Taal W, Domont J, Idbaih A, Campone M, Clement PM, Weller M, Fabbro M, ... ... Platten M, et al. Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study. Neurology. PMID 31076534 DOI: 10.1212/Wnl.0000000000007643  0.309
2019 Schwarz D, Niederle T, Münch P, Hielscher T, Hassel JC, Schlemmer HP, Platten M, Winkler F, Wick W, Heiland S, Delorme S, Bendszus M, Bäumer P, Breckwoldt MO. Susceptibility-weighted imaging in malignant melanoma brain metastasis. Journal of Magnetic Resonance Imaging : Jmri. PMID 30793419 DOI: 10.1002/Jmri.26692  0.67
2019 Eisele P, Konstandin S, Szabo K, Ebert A, Roßmanith C, Paschke N, Kerschensteiner M, Platten M, Schoenberg SO, Schad LR, Gass A. Temporal evolution of acute multiple sclerosis lesions on serial sodium (Na) MRI. Multiple Sclerosis and Related Disorders. 29: 48-54. PMID 30669020 DOI: 10.1016/J.Msard.2019.01.027  0.61
2019 Wick W, Wick A, Platten M, Chinot OL, Van Den Bent MJ, Dhermain F, Mansour M, Podola L, Lubenau H. Oral DNA vaccination targeting VEGFR-2 combined with anti-PD-L1 avelumab in patients with progressive glioblastoma, a phase I/II study: NCT03750071. Journal of Clinical Oncology. 37: TPS2076-TPS2076. DOI: 10.1200/Jco.2019.37.15_Suppl.Tps2076  0.352
2019 Wick W, Kessler T, Platten M, Meisner C, Bamberg M, Herrlinger U, Happold C, Weisang S, Boelting H, Steinbach J, Reifenberger G, Sahm F, von Deimling A, Wick A, Weller M. Impact of predictive impact of MGMT promoter methylation in malignant astrocytomas depends on the methylation subgroup. Journal of Clinical Oncology. 37: 2013-2013. DOI: 10.1200/Jco.2019.37.15_Suppl.2013  0.327
2019 Friedrich M, Bunse L, Bunse T, Green E, Kessler T, Pusch S, Deumelandt K, Carretero R, Deimling Av, Quintana FJ, Wick W, Platten M. Abstract PR15: The oncometabolite R-2-Hydroxyglutarate suppresses the innate immune microenvironment of IDH1-mutated gliomas via aryl hydrocarbon receptor signaling Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-Pr15  0.369
2019 Deumelandt K, Blobner J, Sonner JK, Friedrich M, Green E, Breckwoldt MO, Fischer M, Meyer J, Sahm F, Schrimpf D, Deimling Av, Platten M. Abstract B075: Modeling response and resistance to immune checkpoint blockade in syngeneic mouse glioma Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-B075  0.387
2019 Ulges A, Hilf N, Wick W, Platten M, Dietrich P, Frenzel K, Admon A, Burg SSHvd, Deimling Av, Straten Pt, Gouttefangeas C, Kroep JR, Martínez-Ricarte F, Okada H, Ottensmeier CH, et al. Abstract A020: Immunomonitoring for actively personalized peptide vaccines (APVACs) during immunotherapeutic treatment of glioblastoma Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-A020  0.348
2019 Schmees N, Gutcher I, Roehn U, Irlbacher H, Stoeckigt D, Bader B, Kober C, Roese L, Carretero R, Oezen I, Zorn L, Platten M, Hartung IV, Kreft B, Weinmann H. Abstract 4454: Identification of BAY-218, a potent and selective small-molecule AhR inhibitor, as a new modality to counteract tumor immunosuppression Cancer Research. 79: 4454-4454. DOI: 10.1158/1538-7445.Am2019-4454  0.368
2018 Breckwoldt MO, Bode J, Sahm F, Krüwel T, Solecki G, Hahn A, Wirthschaft P, Berghoff AS, Haas M, Venkataramani V, von Deimling A, Wick W, Herold-Mende C, Heiland S, Platten M, et al. Correlated MRI and Ultramicroscopy (MR-UM) of Brain Tumors Reveals Vast Heterogeneity of Tumor Infiltration and Neoangiogenesis in Preclinical Models and Human Disease. Frontiers in Neuroscience. 12: 1004. PMID 30686972 DOI: 10.3389/Fnins.2018.01004  0.71
2018 Hoffmann A, Pfeil J, Mueller AK, Jin J, Deumelandt K, Helluy X, Wang C, Heiland S, Platten M, Chen JW, Bendszus M, Breckwoldt MO. MRI of Iron Oxide Nanoparticles and Myeloperoxidase Activity Links Inflammation to Brain Edema in Experimental Cerebral Malaria. Radiology. 181051. PMID 30615566 DOI: 10.1148/Radiol.2018181051  0.669
2018 Adam I, Dewi DL, Mooiweer J, Sadik A, Mohapatra SR, Berdel B, Keil M, Sonner JK, Thedieck K, Rose AJ, Platten M, Heiland I, Trump S, Opitz CA. Upregulation of tryptophanyl-tRNA synthethase adapts human cancer cells to nutritional stress caused by tryptophan degradation. Oncoimmunology. 7: e1486353. PMID 30524887 DOI: 10.1080/2162402X.2018.1486353  0.333
2018 Wick W, Dettmer S, Berberich A, Kessler T, Karapanagiotou-Schenkel I, Wick A, Winkler F, Pfaff E, Brors B, Debus J, Unterberg A, Bendszus M, Herold-Mende C, Eisenmenger A, von Deimling A, ... ... Platten M, et al. N2M2 (NOA20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma. Neuro-Oncology. PMID 30277538 DOI: 10.1093/Neuonc/Noy161  0.315
2018 Berberich A, Kessler T, Thomé CM, Pusch S, Hielscher T, Sahm F, Oezen I, Schmitt LM, Ciprut S, Hucke N, Rübmann P, Fischer M, Lemke D, Breckwoldt MO, von Deimling A, ... ... Platten M, et al. Targeting resistance against the MDM2 inhibitor RG7388 in glioblastoma cells by the MEK inhibitor trametinib. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30274984 DOI: 10.1158/1078-0432.Ccr-18-1580  0.66
2018 Platten M. T cells engineered to home in on brain cancer. Nature. 561: 319-320. PMID 30224728 DOI: 10.1038/D41586-018-05883-7  0.311
2018 Friedrich M, Bunse L, Wick W, Platten M. Perspectives of immunotherapy in isocitrate dehydrogenase-mutant gliomas. Current Opinion in Oncology. PMID 30102604 DOI: 10.1097/Cco.0000000000000478  0.316
2018 Shraibman B, Barnea E, Melamed Kadosh D, Haimovich Y, Slobodin G, Rosner I, López-Larrea C, Hilf N, Kuttruff S, Song C, Britten C, Castle J, Kreiter S, Frenzel K, Tatagiba M, ... ... Platten M, et al. Identification of tumor antigens among the HLA peptidomes of Glioblastoma tumors and plasma. Molecular & Cellular Proteomics : McP. PMID 30072578 DOI: 10.1074/Mcp.Ra118.000792  0.355
2018 Berberich A, Hielscher T, Kickingereder P, Winkler F, Drüschler K, Riedemann L, Arzt M, Kessler T, Platten M, von Deimling A, Wick W, Sahm F, Bendszus M, Wick A. Non-measurable speckled contrast-enhancing lesions appearing during course of disease are associated with IDH mutation in high-grade astrocytoma patients. International Journal of Radiation Oncology, Biology, Physics. PMID 30071292 DOI: 10.1016/J.Ijrobp.2018.07.2004  0.343
2018 Bunse L, Pusch S, Bunse T, Sahm F, Sanghvi K, Friedrich M, Alansary D, Sonner JK, Green E, Deumelandt K, Kilian M, Neftel C, Uhlig S, Kessler T, von Landenberg A, ... ... Platten M, et al. Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate. Nature Medicine. PMID 29988124 DOI: 10.1038/S41591-018-0095-6  0.736
2018 Capper D, Stichel D, Sahm F, Jones DTW, Schrimpf D, Sill M, Schmid S, Hovestadt V, Reuss DE, Koelsche C, Reinhardt A, Wefers AK, Huang K, Sievers P, Ebrahimi A, ... ... Platten M, et al. Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathologica. PMID 29967940 DOI: 10.1007/S00401-018-1879-Y  0.34
2018 Shirahata M, Ono T, Stichel D, Schrimpf D, Reuss DE, Sahm F, Koelsche C, Wefers A, Reinhardt A, Huang K, Sievers P, Shimizu H, Nanjo H, Kobayashi Y, Miyake Y, ... ... Platten M, et al. Novel, improved grading system(s) for IDH-mutant astrocytic gliomas. Acta Neuropathologica. PMID 29687258 DOI: 10.1007/S00401-018-1849-4  0.563
2018 Yamauchi Y, Safi S, Blattner C, Rathinasamy A, Umansky L, Juenger S, Warth A, Eichhorn M, Muley T, Herth FJF, Dienemann H, Platten M, Beckhove P, Utikal J, Hoffmann H, et al. Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-small-cell Lung Cancer. American Journal of Respiratory and Critical Care Medicine. PMID 29617574 DOI: 10.1164/Rccm.201708-1707Oc  0.365
2018 Reinhardt A, Stichel D, Schrimpf D, Sahm F, Korshunov A, Reuss DE, Koelsche C, Huang K, Wefers AK, Hovestadt V, Sill M, Gramatzki D, Felsberg J, Reifenberger G, Koch A, ... ... Platten M, et al. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. Acta Neuropathologica. PMID 29564591 DOI: 10.1007/S00401-018-1837-8  0.707
2018 Platten M, Reardon DA. Concepts for Immunotherapies in Gliomas. Seminars in Neurology. 38: 62-72. PMID 29548053 DOI: 10.1055/S-0037-1620274  0.393
2018 Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE, Kratz A, Wefers AK, Huang K, Pajtler KW, Schweizer L, ... ... Platten M, et al. DNA methylation-based classification of central nervous system tumours. Nature. PMID 29539639 DOI: 10.1038/Nature26000  0.653
2018 Schwarzbach CJ, Ebert A, Hennerici MG, Neumaier-Probst E, Platten M, Fatar M. Off-label use of IV t-PA in patients with intracranial neoplasm and cavernoma. Therapeutic Advances in Neurological Disorders. 11: 1756285617753423. PMID 29449886 DOI: 10.1177/1756285617753423  0.314
2018 Rabe JH, A Sammour D, Schulz S, Munteanu B, Ott M, Ochs K, Hohenberger P, Marx A, Platten M, Opitz CA, Ory DS, Hopf C. Fourier Transform Infrared Microscopy Enables Guidance of Automated Mass Spectrometry Imaging to Predefined Tissue Morphologies. Scientific Reports. 8: 313. PMID 29321555 DOI: 10.1038/S41598-017-18477-6  0.319
2018 Wick W, Wick A, Sahm F, Riehl D, von Deimling A, Bendszus M, Kickingereder P, Beckhove P, Schmitz-Winnenthal FH, Jungk C, Wieckowski S, Podola L, Herold-Mende C, Unterberg A, Platten M. VXM01 phase I study in patients with progressive glioblastoma: Final results. Journal of Clinical Oncology. 36: 2017-2017. DOI: 10.1200/Jco.2018.36.15_Suppl.2017  0.344
2018 Lu K, Bunse L, Sahm F, Sanghvi K, Ratliff M, Hänggi D, von Deimling A, Sahin U, Wick W, Green E, Platten M. P04.52 Spontaneous intratumoral T cell responses against glioblastoma-associated antigens Neuro-Oncology. 20: iii291-iii291. DOI: 10.1093/Neuonc/Noy139.286  0.305
2018 Zhang X, Sahm K, Sonner J, Jähne K, Breckwoldt M, Piechutta M, Häring P, Winkler F, Wick W, Platten M. P04.34 Low-dose irradiation increases recruitment and effector function of tumor-specific T cells in experimental gliomas Neuro-Oncology. 20: iii286-iii286. DOI: 10.1093/Neuonc/Noy139.268  0.363
2017 Costa da Silva M, Breckwoldt MO, Vinchi F, Correia MP, Stojanovic A, Thielmann CM, Meister M, Muley T, Warth A, Platten M, Hentze MW, Cerwenka A, Muckenthaler MU. Iron Induces Anti-tumor Activity in Tumor-Associated Macrophages. Frontiers in Immunology. 8: 1479. PMID 29167669 DOI: 10.3389/Fimmu.2017.01479  0.672
2017 Pfaff E, Kessler T, Balasubramanian GP, Berberich A, Schrimpf D, Wick A, Debus J, Unterberg A, Bendszus M, Herold-Mende C, Capper D, Schenkel I, Eisenmenger A, Dettmer S, Brors B, ... Platten M, et al. Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter-hypermethylation - the NCT Neuro Master Match (N2M2) pilot study. Neuro-Oncology. PMID 29165638 DOI: 10.1093/Neuonc/Nox216  0.352
2017 Wick A, Kessler T, Elia AEH, Winkler F, Batchelor TT, Platten M, Wick W. Glioblastoma in the elderly: solid conclusions built on shifting sand? Neuro-Oncology. PMID 29016815 DOI: 10.1093/Neuonc/Nox133  0.301
2017 Kessler T, Sahm F, Sadik A, Stichel D, Hertenstein A, Reifenberger G, Zacher A, Sabel M, Tabatabai G, Steinbach J, Sure U, Krex D, Grosu AL, Bewerunge-Hudler M, Jones D, ... ... Platten M, et al. Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation. Neuro-Oncology. PMID 29016808 DOI: 10.1093/Neuonc/Nox160  0.318
2017 Ochs K, Ott M, Bunse T, Sahm F, Bunse L, Deumelandt K, Sonner JK, Keil M, von Deimling A, Wick W, Platten M. K27M-mutant histone-3 as a novel target for glioma immunotherapy. Oncoimmunology. 6: e1328340. PMID 28811969 DOI: 10.1080/2162402X.2017.1328340  0.348
2017 Eisele P, Szabo K, Alonso A, Ong M, Platten M, Schoenberg SO, Gass A. Lack of T1 hyperintensity in the dentate nucleus after 15 administrations of a macrocyclic contrast agent in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28710325 DOI: 10.1136/Jnnp-2017-316102  0.313
2017 Jung E, Osswald M, Blaes J, Wiestler B, Sahm F, Schmenger T, Solecki G, Deumelandt K, Kurz FT, Xie R, Weil S, Heil O, Thomé C, Gömmel M, Syed M, ... ... Platten M, et al. Tweety-homologue 1 drives brain colonization of gliomas. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28607172 DOI: 10.1523/Jneurosci.3532-16.2017  0.412
2017 Weller M, Roth P, Preusser M, Wick W, Reardon DA, Platten M, Sampson JH. Vaccine-based immunotherapeutic approaches to gliomas and beyond. Nature Reviews. Neurology. PMID 28497804 DOI: 10.1038/Nrneurol.2017.64  0.33
2017 Lanz TV, Williams SK, Stojic A, Iwantscheff S, Sonner JK, Grabitz C, Becker S, Böhler LI, Mohapatra SR, Sahm F, Küblbeck G, Nakamura T, Funakoshi H, Opitz CA, Wick W, ... ... Platten M, et al. Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis. Scientific Reports. 7: 41271. PMID 28117398 DOI: 10.1038/Srep41271  0.32
2017 Wick W, Wick A, Nowosielski M, Sahm F, Riehl D, Arzt M, von Deimling A, Bendszus M, Kickingereder P, Bonekamp D, Beckhove P, Schmitz-Winnenthal FH, Jungk C, Wieckowski S, Herold-Mende C, ... ... Platten M, et al. VXM01 phase I study in patients with resectable progression of a glioblastoma. Journal of Clinical Oncology. 35: 2061-2061. DOI: 10.1200/JCO.2017.35.15_SUPPL.2061  0.3
2017 Nowosielski M, Gorlia T, Bromberg J, Sahm F, Harting I, Kickingereder P, Brandes A, Taphoorn MJB, Taal W, Domont J, Idbaih A, Campone M, Clement P, Weller M, Fabbro M, ... ... Platten M, et al. NIMG-75. NECROSIS DURING TREATMENT IS ASSOCIATED WITH WORSE SURVIVAL IN RECURRENT GLIOBLASTOMA PATIENTS – POST HOC IMAGE ANALYSIS OF EORTC 26101 Neuro-Oncology. 19: vi159-vi159. DOI: 10.1093/Neuonc/Nox168.647  0.303
2017 Klein M, Reijneveld JC, Idbaih A, Brandes A, Taal W, Clement PM, Domont J, Campone M, Taphoorn MJB, Stupp R, Fabbro M, Rhun EL, Dubois F, Weller M, Golfinopoulos V, ... Platten M, et al. NCOG-19. NEUROCOGNITIVE OUTCOMES OF EORTC BRAIN TUMOR GROUP STUDY 26101 PHASE III TRIAL COMPARING THE COMBINATION OF LOMUSTINE AND BEVACIZUMAB WITH LOMUSTINE ALONE IN GLIOBLASTOMA PATIENTS WITH FIRST PROGRESSION Neuro-Oncology. 19: vi142-vi142. DOI: 10.1093/Neuonc/Nox168.580  0.361
2017 Sanghvi K, Green E, Bunse L, Balasubramanian GP, Hertenstein A, Bunse T, Jones D, Sahm F, Wick W, Platten M. P06.08 BRAINTuNE: Brain Tumor Neoepitope Evaluation for personalized glioma immunotherapy Neuro-Oncology. 19: iii50-iii51. DOI: 10.1093/Neuonc/Nox036.182  0.411
2016 Breckwoldt MO, Gradl J, Hähnel S, Hielscher T, Wildemann B, Diem R, Platten M, Wick W, Heiland S, Bendszus M. Increasing the sensitivity of MRI for the detection of multiple sclerosis lesions by long axial coverage of the spinal cord: a prospective study in 119 patients. Journal of Neurology. PMID 27909801 DOI: 10.1007/s00415-016-8353-3  0.625
2016 Schliesser MG, Claus R, Hielscher T, Grimm C, Weichenhan D, Blaes J, Wiestler B, Hau P, Schramm J, Sahm F, Weiß EK, Weiler M, Baer C, Schmidt-Graf F, Schackert G, ... ... Platten M, et al. Prognostic relevance of miRNA-155 methylation in anaplastic glioma. Oncotarget. PMID 27880937 DOI: 10.18632/Oncotarget.13452  0.405
2016 Kirschbaum K, Sonner JK, Zeller MW, Deumelandt K, Bode J, Sharma R, Krüwel T, Fischer M, Hoffmann A, Costa da Silva M, Muckenthaler MU, Wick W, Tews B, Chen JW, Heiland S, ... ... Platten M, et al. In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. PMID 27799546 DOI: 10.1073/pnas.1609397113  0.647
2016 Wick W, Roth P, Hartmann C, Hau P, Nakamura M, Stockhammer F, Sabel MC, Wick A, Koeppen S, Ketter R, Vajkoczy P, Eyupoglu I, Kalff R, Happold C, Galldiks N, ... ... Platten M, et al. Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide. Neuro-Oncology. PMID 27370396 DOI: 10.1093/Neuonc/Now133  0.382
2016 Breckwoldt MO, Bode J, Kurz FT, Hoffmann A, Ochs K, Ott M, Deumelandt K, Krüwel T, Schwarz D, Fischer M, Helluy X, Milford D, Kirschbaum K, Solecki G, Chiblak S, ... ... Platten M, et al. Correlated magnetic resonance imaging and ultramicroscopy (MR-UM) is a tool kit to assess the dynamics of glioma angiogenesis. Elife. 5. PMID 26830460 DOI: 10.7554/eLife.11712  0.686
2016 Sanghvi K, Green E, Bunse T, Bunse L, Sahm F, Omokoko T, Sahin U, Schmitt M, Wick W, Platten M. OS2.6 Identification of IDH1R132H-specific T cell receptors from a humanized mouse model and from glioma patients treated with an IDH1R132H-specific peptide vaccine Neuro-Oncology. 18: iv5-iv6. DOI: 10.1093/Neuonc/Now188.016  0.374
2016 Bunse L, Bunse T, Pusch S, Sahm F, Sanghvi K, Berghoff A, Steadman M, Niemeyer B, Wick W, Platten M. OS2.2 Paracrine impairment of antitumor T cell immunity by IDH1-mutant gliomas Neuro-Oncology. 18: iv4-iv5. DOI: 10.1093/Neuonc/Now188.012  0.337
2016 Thomé C, Blaes J, Sonner J, Deumelandt K, Osswald M, Breckwoldt M, Vajkoczy P, Winkler F, Platten M, Wick W. OS1.3 N-Myc downstream regulated gene 1 (NDRG1) influences the glioma tumor microenvironment Neuro-Oncology. 18: iv2-iv3. DOI: 10.1093/Neuonc/Now188.005  0.339
2015 Ochs K, Ott M, Rauschenbach KJ, Deumelandt K, Sahm F, Opitz CA, von Deimling A, Wick W, Platten M. Tryptophan-2,3-dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor-4. Journal of Neurochemistry. PMID 26708701 DOI: 10.1111/Jnc.13503  0.387
2015 Wick W, Platten M, Wick A, Hertenstein A, Radbruch A, Bendszus M, Winkler F. Current status and future directions of anti-angiogenic therapy for gliomas. Neuro-Oncology. PMID 26459812 DOI: 10.1093/Neuonc/Nov180  0.349
2015 Redaelli C, Gaffarogullari EC, Brune M, Pilz C, Becker S, Sonner J, Jäschke A, Gröne HJ, Wick W, Platten M, Lanz TV. Toxicity of teriflunomide in aryl hydrocarbon receptor deficient mice. Biochemical Pharmacology. 98: 484-92. PMID 26341389 DOI: 10.1016/J.Bcp.2015.08.111  0.315
2015 Reuss DE, Kratz A, Sahm F, Capper D, Schrimpf D, Koelsche C, Hovestadt V, Bewerunge-Hudler M, Jones DT, Schittenhelm J, Mittelbronn M, Rushing E, Simon M, Westphal M, Unterberg A, ... Platten M, et al. Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities. Acta Neuropathologica. PMID 26087904 DOI: 10.1007/S00401-015-1454-8  0.392
2015 Reuss DE, Mamatjan Y, Schrimpf D, Capper D, Hovestadt V, Kratz A, Sahm F, Koelsche C, Korshunov A, Olar A, Hartmann C, Reijneveld JC, Wesseling P, Unterberg A, Platten M, et al. IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO. Acta Neuropathologica. 129: 867-73. PMID 25962792 DOI: 10.1007/S00401-015-1438-8  0.477
2015 Herrlinger U, Platten M. [Treatment of the glioma microenvironment]. Der Nervenarzt. 86: 684, 686-8, 690-1. PMID 25962344 DOI: 10.1007/S00115-014-4225-1  0.402
2015 Platten M, Wick W. Tregs in gliomas - the jury is still out. Neuro-Oncology. 17: 769-70. PMID 25754090 DOI: 10.1093/Neuonc/Nov034  0.416
2015 Bunse L, Schumacher T, Sahm F, Pusch S, Oezen I, Rauschenbach K, Gonzalez M, Solecki G, Osswald M, Capper D, Wiestler B, Winkler F, Herold-Mende C, von Deimling A, Wick W, ... Platten M, et al. Proximity ligation assay evaluates IDH1R132H presentation in gliomas. The Journal of Clinical Investigation. 125: 593-606. PMID 25555220 DOI: 10.1172/Jci77780  0.352
2014 Wick W, Fricke H, Junge K, Kobyakov G, Martens T, Heese O, Wiestler B, Schliesser MG, von Deimling A, Pichler J, Vetlova E, Harting I, Debus J, Hartmann C, Kunz C, ... Platten M, et al. A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6304-13. PMID 25338498 DOI: 10.1158/1078-0432.CCR-14-0951-T  0.361
2014 Wiestler B, Capper D, Hovestadt V, Sill M, Jones DT, Hartmann C, Felsberg J, Platten M, Feiden W, Keyvani K, Pfister SM, Wiestler OD, Meyermann R, Reifenberger G, Pietsch T, et al. Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial. Neuro-Oncology. 16: 1630-8. PMID 25028501 DOI: 10.1093/Neuonc/Nou138  0.387
2014 Wiestler B, Capper D, Sill M, Jones DT, Hovestadt V, Sturm D, Koelsche C, Bertoni A, Schweizer L, Korshunov A, Weiß EK, Schliesser MG, Radbruch A, Herold-Mende C, Roth P, ... ... Platten M, et al. Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma. Acta Neuropathologica. 128: 561-71. PMID 25008768 DOI: 10.1007/S00401-014-1315-X  0.468
2014 Wick W, Platten M. CMV infection and glioma, a highly controversial concept struggling in the clinical arena. Neuro-Oncology. 16: 332-3. PMID 24523454 DOI: 10.1093/Neuonc/Nou002  0.378
2014 Blaes J, Weiler M, Sahm F, Hentschel B, Osswald M, Czabanka M, Thomé CM, Schliesser MG, Pusch S, Luger S, Winkler F, Radbruch A, Jugold M, Simon M, Steinbach JP, ... ... Platten M, et al. NDRG1 prognosticates the natural course of disease in WHO grade II glioma. Journal of Neuro-Oncology. 117: 25-32. PMID 24395351 DOI: 10.1007/s11060-013-1357-2  0.462
2014 Wick W, Wick A, Platten M. Challenging cytomegalovirus data in glioblastoma. Neuro-Oncology. 16: 165. PMID 24353326 DOI: 10.1093/Neuonc/Not212  0.301
2014 Wiestler B, Capper D, Hovestadt V, Sill M, Jones D, Hartmann C, Felsberg J, Platten M, Keyvani K, Pfister S, Wiestler O, Meyermann R, Reifenberger G, Pietsch T, von Deimling A, et al. Determining the glioma CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide methylation data in the biomarker cohort of the NOA-04 trial. Journal of Clinical Oncology. 32: 2017-2017. DOI: 10.1200/Jco.2014.32.15_Suppl.2017  0.315
2014 Wick W, Gorlia T, Van Den Bent MJ, Vecht CJ, Steuve J, Brandes AA, Platten M, Kosch MA, Hegi ME, Lhermitte B, Golfinopoulos V, Campone M, Frenel J, Taphoorn MJ, Pesce GA, et al. Radiation therapy and concurrent plus adjuvant temsirolimus (CCI-779) versus chemoirradiation with temozolomide in newly diagnosed glioblastoma without methylation of the MGMT gene promoter. Journal of Clinical Oncology. 32: 2003-2003. DOI: 10.1200/Jco.2014.32.15_Suppl.2003  0.326
2014 Wick W, Wiestler B, Capper D, Sill M, Hovestadt V, Schliesser MG, Weiss E, Jones DTW, Roth P, Pfister SM, Korshunov A, Platten M, Reifenberger G, von Deimling A, Weller M. PROGNOSTIC AND PREDICTIVE BIOMARKER-BASED SUBGROUPS IN THE NOA-04 TRIAL Neuro-Oncology. 16: iii4-iii4. DOI: 10.1093/Neuonc/Nou206.14  0.382
2013 Koelsche C, Sahm F, Capper D, Reuss D, Sturm D, Jones DT, Kool M, Northcott PA, Wiestler B, Böhmer K, Meyer J, Mawrin C, Hartmann C, Mittelbronn M, Platten M, et al. Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system. Acta Neuropathologica. 126: 907-15. PMID 24154961 DOI: 10.1007/S00401-013-1195-5  0.449
2013 Lanz TV, Becker S, Osswald M, Bittner S, Schuhmann MK, Opitz CA, Gaikwad S, Wiestler B, Litzenburger UM, Sahm F, Ott M, Iwantscheff S, Grabitz C, Mittelbronn M, von Deimling A, ... ... Platten M, et al. Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America. 110: 14735-40. PMID 23959874 DOI: 10.1073/Pnas.1302569110  0.327
2013 Wick W, Steinbach JP, Platten M, Hartmann C, Wenz F, von Deimling A, Shei P, Moreau-Donnet V, Stoffregen C, Combs SE. Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation. Neuro-Oncology. 15: 1405-12. PMID 23911595 DOI: 10.1093/Neuonc/Not100  0.477
2013 Platten M, Wick W, Opitz C. [Immune modulation by tryptophan metabolism: relevance for autoimmune and tumor diseases]. Deutsche Medizinische Wochenschrift (1946). 138: 1478-82. PMID 23821452 DOI: 10.1055/S-0033-1343222  0.329
2013 Wiestler B, Capper D, Holland-Letz T, Deimling Av, Pfister SM, Platten M, Weller M, Wick W. Abstract LB-80: ATRX loss refines the classification of anaplastic glioma and is a favorable prognostic marker. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-80  0.389
2012 Platten M, Weller M, Wick W. Shaping the glioma immune microenvironment through tryptophan metabolism. Cns Oncology. 1: 99-106. PMID 25054303 DOI: 10.2217/Cns.12.6  0.396
2012 Platten M, Wick W, Van den Eynde BJ. Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion. Cancer Research. 72: 5435-40. PMID 23090118 DOI: 10.1158/0008-5472.Can-12-0569  0.388
2012 Ott M, Litzenburger UM, Sahm F, Rauschenbach KJ, Tudoran R, Hartmann C, Marquez VE, von Deimling A, Wick W, Platten M. Promotion of glioblastoma cell motility by enhancer of zeste homolog 2 (EZH2) is mediated by AXL receptor kinase. Plos One. 7: e47663. PMID 23077658 DOI: 10.1371/journal.pone.0047663  0.451
2012 Platten M, Wick W. [Treatment of brain tumor patients: hyperthermia, hyperbaric oxygenation, electric fields or nanoparticles]. Der Nervenarzt. 83: 982-7. PMID 22801663 DOI: 10.1007/S00115-012-3569-7  0.35
2011 Opitz CA, Litzenburger UM, Opitz U, Sahm F, Ochs K, Lutz C, Wick W, Platten M. The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells. Plos One. 6: e19823. PMID 21625531 DOI: 10.1371/Journal.Pone.0019823  0.352
2011 Seidel C, Dörner N, Osswald M, Wick A, Platten M, Bendszus M, Wick W. Does age matter? - A MRI study on peritumoral edema in newly diagnosed primary glioblastoma. Bmc Cancer. 11: 127. PMID 21481277 DOI: 10.1186/1471-2407-11-127  0.377
2010 Platten M, Dörner N, Hofer S, Schäfer N, Schemmer D, Weller M, Bendszus M, Wick W, Wick A. Evaluation of distant spread in bevacizumab-treated versus control-treated patients with malignant gliomas: A matched-pair study. Journal of Clinical Oncology. 28: 2064-2064. DOI: 10.1200/Jco.2010.28.15_Suppl.2064  0.397
2009 Platten M, Youssef S, Hur EM, Ho PP, Han MH, Lanz TV, Phillips LK, Goldstein MJ, Bhat R, Raine CS, Sobel RA, Steinman L. Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proceedings of the National Academy of Sciences of the United States of America. 106: 14948-53. PMID 19706421 DOI: 10.1073/Pnas.0903958106  0.315
2009 Combs SE, Hartmann C, Welzel J, von Deimling A, Debus J, Platten M, Wick W, Gaiser T. Influence of expression of EGFR and PTEN on outcome in patients with primary glioblastoma treated with standard radiochemotherapy and cetuximab: Interim analysis from the GERT-Protocol Journal of Clinical Oncology. 27: 2050-2050. DOI: 10.1200/Jco.2009.27.15_Suppl.2050  0.327
2009 Platten M. Tumorprogress versus therapieinduzierte Veränderungen (Pseudoprogression) bei malignen Astrozytomen Onkopipeline. 2: 16-18. DOI: 10.1007/S15035-009-0139-Y  0.367
2008 Combs SE, Schulz-Ertner D, Hartmann C, Welzel T, Timke C, Herfarth K, von Deimling A, Edler L, Platten M, Wick W, Debus J. Phase I/II study of cetuximab plus temozolomide as radiochemotherapy for primary glioblastoma (GERT)—Eudract number 2005–003911–63; NCT00311857 Journal of Clinical Oncology. 26: 2077-2077. DOI: 10.1200/Jco.2008.26.15_Suppl.2077  0.311
2007 Wick A, Felsberg J, Steinbach JP, Herrlinger U, Platten M, Blaschke B, Meyermann R, Reifenberger G, Weller M, Wick W. Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 3357-61. PMID 17664483 DOI: 10.1200/Jco.2007.10.7722  0.338
2007 Wick W, Wick A, Schuth J, Platten M, Reifenberger G, Weller M. One week on/one week off regimen of temozolomide: Phase II trial in recurrent glioma Journal of Clinical Oncology. 25: 2032-2032. DOI: 10.1200/Jco.2007.25.18_Suppl.2032  0.335
2005 Platten M, Ho PP, Youssef S, Fontoura P, Garren H, Hur EM, Gupta R, Lee LY, Kidd BA, Robinson WH, Sobel RA, Selley ML, Steinman L. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science (New York, N.Y.). 310: 850-5. PMID 16272121 DOI: 10.1126/Science.1117634  0.301
2000 Roth W, Wild-Bode C, Platten M, Grimmel C, Melkonyan HS, Dichgans J, Weller M. Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene. 19: 4210-20. PMID 10980594 DOI: 10.1038/Sj.Onc.1203783  0.355
1997 Platten M, Meyer-Puttlitz B, Blümcke I, Waha A, Wolf HK, Nöthen MM, Louis DN, Sampson JR, von Deimling A. A novel splice site associated polymorphism in the tuberous sclerosis 2 (TSC2) gene may predispose to the development of sporadic gangliogliomas. Journal of Neuropathology and Experimental Neurology. 56: 806-10. PMID 9210877 DOI: 10.1097/00005072-199756070-00007  0.52
1996 Platten M, Giordano MJ, Dirven CM, Gutmann DH, Louis DN. Up-regulation of specific NF 1 gene transcripts in sporadic pilocytic astrocytomas. The American Journal of Pathology. 149: 621-7. PMID 8702000  0.428
Low-probability matches (unlikely to be authored by this person)
2020 Wick W, Wick A, Chinot OL, Bent MJVD, Vos FYFLD, Mansour M, Podola L, Lubenau H, Platten M. Oral DNA vaccination targeting VEGFR2 combined with anti-PDL1 avelumab in patients with progressive glioblastoma: Safety run-in results—NCT03750071. Journal of Clinical Oncology. 38: 3001-3001. DOI: 10.1200/Jco.2020.38.15_Suppl.3001  0.298
2002 Herrlinger U, Küker W, Platten M, Dichgans J, Weller M. First-line therapy with temozolomide induces regression of primary CNS lymphoma. Neurology. 58: 1573-4. PMID 12034807 DOI: 10.1212/Wnl.58.10.1573  0.298
2019 Schiff D, van den Bent M, Vogelbaum MA, Wick W, Miller CR, Taphoorn M, Pope W, Brown PD, Platten M, Jalali R, Armstrong T, Wen PY. Recent Developments and Future Directions in Adult Lower-Grade Gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) Consensus. Neuro-Oncology. PMID 30753579 DOI: 10.1093/Neuonc/Noz033  0.298
2014 Tabatabai G, Wick W, Steinbach JP, Wick A, Schnell O, Hau P, Herrlinger U, Sabel M, Wirsching H, Ketter R, Baehr O, Platten M, Tonn J, Huesing J, Reifenberger G, et al. MGMT promoter methylation as a prognostic biomarker for benefit from dose-intensified temozolomide rechallenge in progressive glioblastoma: First results from the randomized phase II DIRECTOR trial. Journal of Clinical Oncology. 32: 2015-2015. DOI: 10.1200/Jco.2014.32.15_Suppl.2015  0.297
2014 Platten M, Fricke H, Junge K, Kobyakov G, Martens T, Heese O, Wiestler B, Schliesser MG, von Deimling A, Pichler J, Vetlova E, Harting I, Debus J, Hartmann C, Kunz C, et al. Final results of APG101_CD_002: APG101 plus reirradiation versus reirradiation in the treatment of patients with progressive glioblastoma. Journal of Clinical Oncology. 32: 2006-2006. DOI: 10.1200/Jco.2014.32.15_Suppl.2006  0.297
2021 Kilian M, Bunse T, Wick W, Platten M, Bunse L. Genetically Modified Cellular Therapies for Malignant Gliomas. International Journal of Molecular Sciences. 22. PMID 34884607 DOI: 10.3390/ijms222312810  0.297
2007 Kaper T, Looger LL, Takanaga H, Platten M, Steinman L, Frommer WB. Nanosensor detection of an immunoregulatory tryptophan influx/kynurenine efflux cycle. Plos Biology. 5: e257. PMID 17896864 DOI: 10.1371/Journal.Pbio.0050257  0.297
2005 Ho PP, Fontoura P, Platten M, Sobel RA, DeVoss JJ, Lee LY, Kidd BA, Tomooka BH, Capers J, Agrawal A, Gupta R, Zernik J, Yee MK, Lee BJ, Garren H, et al. A suppressive oligodeoxynucleotide enhances the efficacy of myelin cocktail/IL-4-tolerizing DNA vaccination and treats autoimmune disease. Journal of Immunology (Baltimore, Md. : 1950). 175: 6226-34. PMID 16237121 DOI: 10.4049/Jimmunol.175.9.6226  0.297
2012 Lemke D, Pfenning PN, Sahm F, Klein AC, Kempf T, Warnken U, Schnölzer M, Tudoran R, Weller M, Platten M, Wick W. Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 105-17. PMID 22080438 DOI: 10.1158/1078-0432.CCR-11-0880  0.297
2006 Platten M, Ho PP, Steinman L. Anti-inflammatory strategies for the treatment of multiple sclerosis - tryptophan catabolites may hold the key Drug Discovery Today: Therapeutic Strategies. 3: 401-408. DOI: 10.1016/J.Ddstr.2006.09.005  0.297
2017 Wick W, Gorlia T, Bendszus M, Taphoorn M, Sahm F, Harting I, Brandes AA, Taal W, Domont J, Idbaih A, Campone M, Clement PM, Stupp R, Fabbro M, Le Rhun E, ... ... Platten M, et al. Lomustine and Bevacizumab in Progressive Glioblastoma. The New England Journal of Medicine. 377: 1954-1963. PMID 29141164 DOI: 10.1056/Nejmoa1707358  0.294
2003 Friese MA, Platten M, Lutz SZ, Naumann U, Aulwurm S, Bischof F, Bühring HJ, Dichgans J, Rammensee HG, Steinle A, Weller M. MICA/NKG2D-mediated immunogene therapy of experimental gliomas. Cancer Research. 63: 8996-9006. PMID 14695218  0.294
2018 Platten M, Schilling D, Bunse L, Wick A, Bunse T, Riehl D, Green E, Sanghvi K, Karapanagiotou-Schenkel I, Harting I, Sahm F, Steinbach J, Weyerbrock A, Hense J, Misch M, et al. ATIM-33. NOA-16: A FIRST-IN-MAN MULTICENTER PHASE I CLINICAL TRIAL OF THE GERMAN NEUROONCOLOGY WORKING GROUP EVALUATING A MUTATION-SPECIFIC PEPTIDE VACCINE TARGETING IDH1R132H IN PATIENTS WITH NEWLY DIAGNOSED MALIGNANT ASTROCYTOMAS Neuro-Oncology. 20: vi8-vi9. DOI: 10.1093/Neuonc/Noy148.028  0.293
2016 Wick W, Gorlia T, Bady P, Platten M, van den Bent MJ, Taphoorn MJ, Steuve J, Brandes AA, Hamou MF, Wick A, Kosch M, Weller M, Stupp R, Roth P, Golfinopoulos V, et al. Phase II study of radiotherapy and temsirolimus versus radiochemotherapy with temozolomide in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation (EORTC 26082). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27143690 DOI: 10.1158/1078-0432.Ccr-15-3153  0.293
2019 Berberich A, Schmitt LM, Pusch S, Hielscher T, Rübmann P, Hucke N, Latzer P, Heßling B, Lemke D, Kessler T, Platten M, Wick W. cMyc and ERK activity are associated with resistance to ALK inhibitory treatment in glioblastoma. Journal of Neuro-Oncology. PMID 31776900 DOI: 10.1007/S11060-019-03348-Z  0.292
2011 Hertenstein A, Schumacher T, Litzenburger U, Opitz CA, Falk CS, Serafini T, Wick W, Platten M. Suppression of human CD4+ T cell activation by 3,4-dimethoxycinnamonyl-anthranilic acid (tranilast) is mediated by CXCL9 and CXCL10. Biochemical Pharmacology. 82: 632-41. PMID 21703247 DOI: 10.1016/J.Bcp.2011.06.013  0.291
2020 Weber CE, Ebert A, Platten M, Gass A, Eisele P. Susceptibility-Weighted 3T MRI of the Swallow Tail Sign in Multiple Sclerosis: A Case Control Study. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 32857891 DOI: 10.1111/Jon.12775  0.291
2016 Kleist C, Mohr E, Gaikwad S, Dittmar L, Kuerten S, Platten M, Mier W, Schmitt M, Opelz G, Terness P. Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis. Journal of Translational Medicine. 14: 99. PMID 27131971 DOI: 10.1186/S12967-016-0860-6  0.289
2017 Lanz TV, Becker S, Mohapatra SR, Opitz CA, Wick W, Platten M. Suppression of Th1 differentiation by tryptophan supplementation in vivo. Amino Acids. PMID 28421297 DOI: 10.1007/S00726-017-2415-4  0.288
2017 Mildenberger I, Bunse L, Ochs K, Platten M. The promises of immunotherapy in gliomas. Current Opinion in Neurology. PMID 28984704 DOI: 10.1097/Wco.0000000000000491  0.287
2019 Paech D, Kuder TA, Roßmanith C, Griebe M, Eisele P, Platten M, Ladd ME, Schlemmer HP, Gass A, Szabo K. What remains after transient global amnesia (TGA)? An ultra-high field 7T magnetic resonance imaging study of the hippocampus. European Journal of Neurology. PMID 31573112 DOI: 10.1111/Ene.14099  0.286
2017 Friedrich M, Bunse L, Bunse T, Pusch S, Sahm F, Sanghvi K, Steadman M, Niemeyer B, Wick W, Platten M. OS10.2 R-2-Hydroxyglutarate shapes the immune microenvironment in IDH1-mutant gliomas Neuro-Oncology. 19: iii20-iii21. DOI: 10.1093/Neuonc/Nox036.070  0.286
2019 Eisele P, Szabo K, Ebert A, Radbruch A, Platten M, Schoenberg SO, Gass A. Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosis. Magnetic Resonance Imaging. 58: 1-5. PMID 30630068 DOI: 10.1016/J.Mri.2019.01.007  0.286
2020 Berberich A, Bartels F, Tang Z, Knoll M, Pusch S, Hucke N, Kessler T, Dong Z, Wiestler B, Winkler F, Platten M, Wick W, Abdollahi A, Lemke D. -CD40 Crosstalk in Glioblastoma Invasion and Temozolomide Resistance. Frontiers in Oncology. 10: 747. PMID 32582531 DOI: 10.3389/Fonc.2020.00747  0.286
2019 Anssar TM, Leitzmann MF, Linker RA, Meier C, Becker C, Jick S, Sahm K, Platten M, Hau P, Seliger C. Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma. Cancer Medicine. PMID 31821741 DOI: 10.1002/Cam4.2767  0.285
2015 Kessler T, Sahm F, Blaes J, Osswald M, Rübmann P, Milford D, Urban S, Jestaedt L, Heiland S, Bendszus M, Hertenstein A, Pfenning PN, Ruiz de Almodóvar C, Wick A, Winkler F, ... ... Platten M, et al. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma. Oncotarget. PMID 25682871 DOI: 10.18632/oncotarget.2910  0.285
2014 Litzenburger UM, Opitz CA, Sahm F, Rauschenbach KJ, Trump S, Winter M, Ott M, Ochs K, Lutz C, Liu X, Anastasov N, Lehmann I, Höfer T, von Deimling A, Wick W, ... Platten M, et al. Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR. Oncotarget. 5: 1038-51. PMID 24657910 DOI: 10.18632/Oncotarget.1637  0.285
2014 Lemke D, Weiler M, Blaes J, Wiestler B, Jestaedt L, Klein AC, Löw S, Eisele G, Radlwimmer B, Capper D, Schmieder K, Mittelbronn M, Combs SE, Bendszus M, Weller M, ... Platten M, et al. Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity? Journal of Neurochemistry. PMID 24976529 DOI: 10.1111/Jnc.12802  0.284
2018 Friedrich M, Bunse L, Bunse T, Green E, Kessler T, Pusch S, Sanghvi K, Carretero R, Gutcher I, von Deimling A, Wick W, Platten M. P04.62 The oncometabolite R-2-Hydroxyglutarate suppresses the innate immune microenvironment of IDH1-mutated gliomas via aryl hydrocarbon receptor signaling Neuro-Oncology. 20: iii293-iii294. DOI: 10.1093/Neuonc/Noy139.296  0.283
2018 Eisele P, Szabo K, Ebert A, Platten M, Gass A. Brain Atrophy in Natalizumab-treated Patients with Multiple Sclerosis: A 5-year Retrospective Study. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 30485572 DOI: 10.1111/Jon.12586  0.283
2016 van den Bent M, Gorlia T, Bendszus M, Sahm F, Domont J, Idbaih A, Platten M, Weller M, Golfoinopoulos V, Wick W. EH1.3 EORTC 26101 phase III trial exploring the combination of bevacizumab and lomustine versus lomustine in patients with first progression of a glioblastoma Neuro-Oncology. 18: iv1-iv2. DOI: 10.1093/Neuonc/Now188.002  0.283
2016 Sonner JK, Deumelandt K, Ott M, Thomé CM, Rauschenbach KJ, Schulz S, Munteanu B, Mohapatra S, Adam I, Hofer AC, Feuerer M, Opitz CA, Hopf C, Wick W, Platten M. The stress kinase GCN2 does not mediate suppression of antitumor T cell responses by tryptophan catabolism in experimental melanomas. Oncoimmunology. 5: e1240858. PMID 28123877 DOI: 10.1080/2162402X.2016.1240858  0.282
2004 Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ma JY, Almirez R, Mangadu R, Liu YW, Platten M, Herrlinger U, Murphy A, Wong DH, Wick W, Higgins LS, Weller M. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. Cancer Research. 64: 7954-61. PMID 15520202 DOI: 10.1158/0008-5472.Can-04-1013  0.282
2023 Friedrich MJ, Neri P, Kehl N, Michel J, Steiger S, Kilian M, Leblay N, Maity R, Sankowski R, Lee H, Barakat E, Ahn S, Weinhold N, Rippe K, Bunse L, ... Platten M, et al. The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients. Cancer Cell. PMID 36898378 DOI: 10.1016/j.ccell.2023.02.008  0.279
2003 Platten M, Kretz A, Naumann U, Aulwurm S, Egashira K, Isenmann S, Weller M. Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas. Annals of Neurology. 54: 388-92. PMID 12953273 DOI: 10.1002/ana.10679  0.279
2018 Kessler T, Sahm F, Balasubramanian GP, Pfaff E, Jones DTW, Wick A, Debus J, Unterberg A, Berberich A, Herold-Mende C, Pfister SM, Brors B, Dettmer S, Karapanagiotou-Schenkel I, Winkler F, ... ... Platten M, et al. Towards a molecular algorithm predicting glioma treatment response and resistance: A biomarker analysis and path to real time profiling in N2M2. Journal of Clinical Oncology. 36: 12090-12090. DOI: 10.1200/Jco.2018.36.15_Suppl.12090  0.279
2019 Sonner JK, Keil M, Falk-Paulsen M, Mishra N, Rehman A, Kramer M, Deumelandt K, Röwe J, Sanghvi K, Wolf L, von Landenberg A, Wolff H, Bharti R, Oezen I, Lanz TV, ... ... Platten M, et al. Dietary tryptophan links encephalogenicity of autoreactive T cells with gut microbial ecology. Nature Communications. 10: 4877. PMID 31653831 DOI: 10.1038/S41467-019-12776-4  0.279
2022 Kilian M, Sheinin R, Tan CL, Friedrich M, Krämer C, Kaminitz A, Sanghvi K, Lindner K, Chih YC, Cichon F, Richter B, Jung S, Jähne K, Ratliff M, Prins RM, ... ... Platten M, et al. MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors. Cancer Cell. PMID 36638785 DOI: 10.1016/j.ccell.2022.12.007  0.278
2011 Weller M, Platten M, Roth P, Wick W. Geriatric neuro-oncology: from mythology to biology. Current Opinion in Neurology. 24: 599-604. PMID 21968549 DOI: 10.1097/WCO.0b013e32834c4967  0.277
2022 Elmadany N, Alhalabi OT, Platten M, Bunse L. Site-Specific Considerations on Engineered T Cells for Malignant Gliomas. Biomedicines. 10. PMID 35885047 DOI: 10.3390/biomedicines10071738  0.277
2022 Friedrich M, Hahn M, Michel J, Sankowski R, Kilian M, Kehl N, Günter M, Bunse T, Pusch S, von Deimling A, Wick W, Autenrieth SE, Prinz M, Platten M, Bunse L. Dysfunctional dendritic cells limit antigen-specific T cell response in glioma. Neuro-Oncology. PMID 35609569 DOI: 10.1093/neuonc/noac138  0.275
2018 Sahm K, Mildenberger I, Bunse L, Green E, Wick W, Platten M. P01.140 An H3.3K27M long peptide vaccine induces expansion of specific CD4 and CD8 T cell clones in a patient with progressive H3.3K27M-mutant midline glioma Neuro-Oncology. 20: iii264-iii264. DOI: 10.1093/Neuonc/Noy139.182  0.275
2015 Reuss DE, Sahm F, Schrimpf D, Wiestler B, Capper D, Koelsche C, Schweizer L, Korshunov A, Jones DT, Hovestadt V, Mittelbronn M, Schittenhelm J, Herold-Mende C, Unterberg A, Platten M, et al. ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. Acta Neuropathologica. 129: 133-46. PMID 25427834 DOI: 10.1007/s00401-014-1370-3  0.275
2020 Chuntova P, Chow F, Watchmaker P, Galvez M, Heimberger AB, Newell EW, Diaz A, DePinho RA, Li MO, Wherry EJ, Mitchell D, Terabe M, Wainwright DA, Berzofsky JA, Herold-Mende C, ... ... Platten M, et al. Unique challenges for glioblastoma immunotherapy - Discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Neuro-Oncology. PMID 33367885 DOI: 10.1093/neuonc/noaa277  0.274
2022 Bunse L, Bunse T, Krämer C, Chih YC, Platten M. Clinical and Translational Advances in Glioma Immunotherapy. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 36303101 DOI: 10.1007/s13311-022-01313-9  0.273
2018 Wick A, Kessler T, Platten M, Meisner C, Bamberg M, Herrlinger U, Felsberg J, Weyerbrock A, Seidel C, Steinbach JP, Sabel M, Vesper J, Debus J, Sahm F, Meixensberger J, et al. P01.013 Long-term analyses of the NOA-08 randomized phase III trial of temozolomide versus radiotherapy for elderly patients with malignant astrocytomas Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy139.055  0.273
2010 Lanz TV, Ding Z, Ho PP, Luo J, Agrawal AN, Srinagesh H, Axtell R, Zhang H, Platten M, Wyss-Coray T, Steinman L. Angiotensin II sustains brain inflammation in mice via TGF-beta. The Journal of Clinical Investigation. 120: 2782-94. PMID 20628203 DOI: 10.1172/Jci41709  0.273
2012 Platten M, Opitz C, Wick W. The aryl hydrocarbon receptor as a promoter of malignant glioma. Cell Cycle (Georgetown, Tex.). 11: 643-4. PMID 22374665 DOI: 10.4161/Cc.11.4.19357  0.272
2009 Wick Wolfgang W, Combs SE, Platten M, Weller M, Ohnmacht U, Stoffregen C, Thornton D. Enzastaurin (ENZ) before and concomitant with radiation therapy (RTX), followed by ENZ maintenance therapy in patients with newly diagnosed glioblastoma (GBM) without hypermethylation of the O6-methylguanyl DNA-methyltransferase (MGMT) promoter: A multicenter, open-label, uncontrolled phase II study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e13038. PMID 27962863 DOI: 10.1200/Jco.2011.29.15_Suppl.2007  0.272
2019 Kickingereder P, Isensee F, Tursunova I, Petersen J, Neuberger U, Bonekamp D, Brugnara G, Schell M, Kessler T, Foltyn M, Harting I, Sahm F, Prager M, Nowosielski M, Wick A, ... ... Platten M, et al. Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study. The Lancet. Oncology. PMID 30952559 DOI: 10.1016/S1470-2045(19)30098-1  0.271
2017 Deumelandt K, Platten M, Ochs K. Synergy of vaccination and agonist OX40 treatment-toward a mechanism-driven combination of glioma immunotherapy. Neuro-Oncology. PMID 29092058 DOI: 10.1093/Neuonc/Nox169  0.271
2021 Friedrich M, Sankowski R, Bunse L, Kilian M, Green E, Ramallo Guevara C, Pusch S, Poschet G, Sanghvi K, Hahn M, Bunse T, Münch P, Gegner HM, Sonner JK, von Landenberg A, ... ... Platten M, et al. Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas. Nature Cancer. 2: 723-740. PMID 35121943 DOI: 10.1038/s43018-021-00201-z  0.27
2020 Wick A, Kessler T, Platten M, Meisner C, Bamberg M, Herrlinger U, Felsberg J, Weyerbrock A, Papsdorf K, Steinbach JP, Sabel M, Vesper J, Debus J, Meixensberger J, Ketter R, et al. Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter-methylated malignant astrocytoma. Neuro-Oncology. PMID 32064499 DOI: 10.1093/Neuonc/Noaa033  0.268
2017 Kessler T, Sahm F, Sadik A, Hertenstein A, Bendszus M, von Deimling A, Platten M, Wick W. OS07.1 Molecular differences in IDH wild type glioblastoma according to MGMT promoter methylation status Neuro-Oncology. 19: iii12-iii13. DOI: 10.1093/Neuonc/Nox036.042  0.267
2014 Schumacher T, Bunse L, Wick W, Platten M. Mutant IDH1: An immunotherapeutic target in tumors. Oncoimmunology. 3: e974392. PMID 25964867 DOI: 10.4161/2162402X.2014.974392  0.267
2019 Lanz TV, Pröbstel AK, Mildenberger I, Platten M, Schirmer L. Single-Cell High-Throughput Technologies in Cerebrospinal Fluid Research and Diagnostics. Frontiers in Immunology. 10: 1302. PMID 31244848 DOI: 10.3389/Fimmu.2019.01302  0.267
2016 van den Bent M, Clement P, Vos F, Platten M, Mulholland P, Taphoorn M, Lewis J, Gorlia T, Golfinopoulos V, Idbaih A, Chinot O. ACTR-09. CLINICAL RESULTS OF THE EORTC RANDOMIZED PHASE II TAVAREC TRIAL ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB IN 1ST RECURRENCE OF GRADE II OR III GLIOMA WITHOUT 1p/19q CO-DELETION Neuro-Oncology. 18: vi3-vi3. DOI: 10.1093/Neuonc/Now212.008  0.267
2009 Wick A, Dörner N, Heiland S, Hartmann C, Platten M, Bendszus M, Wick W. MRT Verlaufsuntersuchungen unter Bevacizumab: Bedeutung von MGMT? Aktuelle Neurologie. 36. DOI: 10.1055/S-0029-1238503  0.267
2014 Platten M, Ochs K, Lemke D, Opitz C, Wick W. Microenvironmental clues for glioma immunotherapy. Current Neurology and Neuroscience Reports. 14: 440. PMID 24604058 DOI: 10.1007/s11910-014-0440-1  0.267
2019 Eisele P, Fischer K, Szabo K, Platten M, Gass A. Characterization of Contrast-Enhancing and Non-contrast-enhancing Multiple Sclerosis Lesions Using Susceptibility-Weighted Imaging. Frontiers in Neurology. 10: 1082. PMID 31681152 DOI: 10.3389/Fneur.2019.01082  0.266
2016 Idbaih A, Clement PM, Vos FY, Platten M, Mulholland P, Taphoorn MJ, Lewis L, Golfinopoulos V, Gorlia T, van den Bent MJ. OS5.7 First results of the randomized phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact 1st recurrence grade II and III glioma Neuro-Oncology. 18: iv13-iv13. DOI: 10.1093/Neuonc/Now188.041  0.265
2000 von Deimling A, Fimmers R, Schmidt MC, Bender B, Fassbender F, Nagel J, Jahnke R, Kaskel P, Duerr EM, Koopmann J, Maintz D, Steinbeck S, Wick W, Platten M, Müller DJ, et al. Comprehensive allelotype and genetic anaysis of 466 human nervous system tumors. Journal of Neuropathology and Experimental Neurology. 59: 544-58. PMID 10850867 DOI: 10.1093/Jnen/59.6.544  0.265
2019 Platten M, Nollen EAA, Röhrig UF, Fallarino F, Opitz CA. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nature Reviews. Drug Discovery. PMID 30760888 DOI: 10.1038/S41573-019-0016-5  0.264
2018 Platten M, Bunse L, Riehl D, Bunse T, Ochs K, Wick W. Vaccine Strategies in Gliomas. Current Treatment Options in Neurology. 20: 11. PMID 29594595 DOI: 10.1007/S11940-018-0498-1  0.263
2020 Szabo K, Hoyer C, Caplan LR, Grassl R, Griebe M, Ebert A, Platten M, Gass A. Diffusion-weighted MRI in transient global amnesia and its diagnostic implications. Neurology. PMID 32532848 DOI: 10.1212/Wnl.0000000000009783  0.263
2019 Alonso A, Etminan N, Krebs J, Szabo K, Platten M, Förster A. Fulminant Cytotoxic Edema in a Patient with Pneumococcal Meningoencephalitis. Journal of Clinical Neurology (Seoul, Korea). 15: 575-577. PMID 31591850 DOI: 10.3988/Jcn.2019.15.4.575  0.263
2016 Ochs K, Capper D, Sahm F, Jones DT, Schrimpf D, von Deimling A, Wick W, Platten M. P02.03 Multiple sclerosis and gliomas - a coincidence? Neuro-Oncology. 18: iv22-iv22. DOI: 10.1093/Neuonc/Now188.073  0.262
2017 Ochs K, Ott M, Bunse T, Sahm F, Bunse L, Keil M, Deumelandt K, Sonner J, von Deimling A, Wick W, Platten M. P06.06 A mutation-specific vaccine for Histone-3 K27M-mutated gliomas Neuro-Oncology. 19: iii50-iii50. DOI: 10.1093/Neuonc/Nox036.180  0.262
2018 Latzer P, Kessler T, Sahm F, Rübmann P, Hielscher T, Platten M. P04.30 Methadone does not increase toxicity of temozolomide in glioblastoma cells Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy139.264  0.261
2021 Costa B, Fletcher MNC, Boskovic P, Ivanova EL, Eisemann T, Lohr S, Bunse L, Löwer M, Burchard S, Korshunov A, Coltella N, Cusimano M, Naldini L, Liu HK, Platten M, et al. A Set of Cell Lines Derived from a Genetic Murine Glioblastoma Model Recapitulates Molecular and Morphological Characteristics of Human Tumors. Cancers. 13. PMID 33435218 DOI: 10.3390/cancers13020230  0.26
2020 Lindner K, Tan CL, Bozza M, Sanghvi K, Poschke I, Harbottle R, von Deimling A, Wick W, Sahm F, Platten M, Green EW, Bunse L. IMMU-41. HIGH-THROUGHPUT RETRIEVAL OF THERAPEUTIC T CELL RECEPTORS FROM GLIOMA Neuro-Oncology. 22: ii113-ii113. DOI: 10.1093/neuonc/noaa215.471  0.26
2017 Nowosielski M, Gorlia T, Harting I, Radbruch A, Brandes A, Taphoorn MJB, Taal W, Domont J, Idbaih A, Campone M, Clement PM, Stupp R, Fabbro M, Rhun EL, von Deimling A, ... Platten M, et al. NIMG-51. RADIOLOGIC PHENOTYPES ARE TREATMENT SPECIFIC AND ASSOCIATED WITH SURVIVAL - EXPLORATORY ANALYSIS OF EORTC 26101 Neuro-Oncology. 19: vi153-vi153. DOI: 10.1093/Neuonc/Nox168.625  0.259
2020 Weber CE, Sandikci V, Ebert A, Szabo K, Platten M, Gass A, Eisele P. Investigation of the "central vein sign" in infratentorial multiple sclerosis lesions. Multiple Sclerosis and Related Disorders. 45: 102409. PMID 32711298 DOI: 10.1016/J.Msard.2020.102409  0.258
2018 Ochs K, Bunse L, Mildenberger I, Wick W, Platten M. Immuntherapien bei Gliomen Best Practice Onkologie. 13: 196-204. DOI: 10.1007/S00761-017-0258-Y  0.256
2018 Dietrich P, Wick W, Hilf N, Frenzel K, Gouttefangeas C, Platten M, Straten Pt, Lassen U, Rodon J, Bukur V, Admon A, Burg SHvd, Deimling Av, Kroep JR, Martinez-Ricarte F, et al. OS2.2 Highly personalized peptide vaccination for patients with newly diagnosed glioblastoma: the GAPVAC trial Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy139.015  0.255
2008 Wick W, Stupp R, Beule AC, Bromberg J, Wick A, Ernemann U, Platten M, Marosi C, Mason WP, van den Bent M, Weller M, Rorden C, Karnath HO. A novel tool to analyze MRI recurrence patterns in glioblastoma. Neuro-Oncology. 10: 1019-24. PMID 18676355 DOI: 10.1215/15228517-2008-058  0.255
2019 Mildenberger I, Eisele P, Hofheinz R, Platten M. [Treatment-associated neurological symptoms of cancer patients and their treatment]. Der Nervenarzt. PMID 31089783 DOI: 10.1007/S00115-019-0712-8  0.254
2021 Panitz V, Končarević S, Sadik A, Friedel D, Bausbacher T, Trump S, Farztdinov V, Schulz S, Sievers P, Schmidt S, Jürgenson I, Jung S, Kuhn K, Pflüger I, Sharma S, ... ... Platten M, et al. Tryptophan metabolism is inversely regulated in the tumor and blood of patients with glioblastoma. Theranostics. 11: 9217-9233. PMID 34646367 DOI: 10.7150/thno.60679  0.253
2018 Eisele P, Szabo K, Ebert A, Brueck W, Platten M, Gass A. Spatiotemporal evolution of venous narrowing in acute MS lesions. Neurology(R) Neuroimmunology & Neuroinflammation. 5: e440. PMID 29359176 DOI: 10.1212/Nxi.0000000000000440  0.253
2011 Wick W, Winkler F, Platten M. Chemotherapy of gliomas | Chemotherapie bei Gliomen Onkologe. 17: 44-54. DOI: 10.1007/S00761-010-1962-Z  0.253
2013 Wiestler B, Capper D, Holland-Letz T, Korshunov A, von Deimling A, Pfister SM, Platten M, Weller M, Wick W. ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis. Acta Neuropathologica. 126: 443-51. PMID 23904111 DOI: 10.1007/s00401-013-1156-z  0.253
2013 Platten M, Lanz T, Bendszus M, Diem R. [Clinically isolated syndrome]. Der Nervenarzt. 84: 1247-59. PMID 24081277 DOI: 10.1007/S00115-013-3845-1  0.252
2001 Wick W, Grimmel C, Wild-Bode C, Platten M, Arpin M, Weller M. Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 3360-8. PMID 11331365 DOI: 10.1523/Jneurosci.21-10-03360.2001  0.251
2018 Wick W, Dietrich P, HIlf N, Platten M, Frenzel K, Admon A, van der Burg S, von Deimling A, Gouttefangeas C, Kroep J, Martinez-Ricarte F, Okada H, Ottensmeier C, Ponsati B, Poulsen H, et al. ATIM-20. GAPVAC-101 TRIAL OF A HIGHLY PERSONALIZED PEPTIDE VACCINATION FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA Neuro-Oncology. 20: vi5-vi5. DOI: 10.1093/Neuonc/Noy148.015  0.25
2022 Kehl N, Kilian M, Michel J, Wagner TR, Uhrig S, Brobeil A, Sester LS, Blobner S, Steiger S, Hundemer M, Weinhold N, Rippe K, Fröhling S, Eichmüller SB, Bunse L, ... ... Platten M, et al. IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells. Journal For Immunotherapy of Cancer. 10. PMID 36252999 DOI: 10.1136/jitc-2022-005815  0.248
2022 Hwang EI, Sayour EJ, Flores CT, Grant G, Wechsler-Reya R, Hoang-Minh LB, Kieran MW, Salcido J, Prins RM, Figg JW, Platten M, Candelario KM, Hale PG, Blatt JE, Governale LS, et al. The current landscape of immunotherapy for pediatric brain tumors. Nature Cancer. 3: 11-24. PMID 35121998 DOI: 10.1038/s43018-021-00319-0  0.248
2008 Combs S, Schulz-Ertner D, Hartmann C, Welzel T, Timke C, Herfarth K, von Deimling A, Platten M, Wick W, Debus J. Erbitux® (Cetuximab) Plus Temozolomide as Radiochemotherapy for Primary Glioblastoma (GERT): Interim Results of a Phase I/II Study International Journal of Radiation Oncology*Biology*Physics. 72: S10-S11. DOI: 10.1016/J.Ijrobp.2008.06.790  0.248
2017 Schulte KW, Green E, Wilz A, Platten M, Daumke O. Structural Basis for Aryl Hydrocarbon Receptor-Mediated Gene Activation. Structure (London, England : 1993). PMID 28602820 DOI: 10.1016/J.Str.2017.05.008  0.248
2011 Mittelbronn M, Platten M, Zeiner P, Dombrowski Y, Frank B, Zachskorn C, Harter PN, Weller M, Wischhusen J. Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression. Acta Neuropathologica. 122: 353-65. PMID 21773885 DOI: 10.1007/s00401-011-0858-3  0.245
2011 Wick A, Dörner N, Schäfer N, Hofer S, Heiland S, Schemmer D, Platten M, Weller M, Bendszus M, Wick W. Bevacizumab does not increase the risk of remote relapse in malignant glioma. Annals of Neurology. 69: 586-92. PMID 21446027 DOI: 10.1002/ana.22336  0.244
2013 Reuss DE, Mucha J, Holtkamp N, Müller U, Berlien HP, Mautner VF, Ehemann V, Platten M, Scheffzek K, von Deimling A. Functional MHC class II is upregulated in neurofibromin-deficient Schwann cells. The Journal of Investigative Dermatology. 133: 1372-5. PMID 23303456 DOI: 10.1038/Jid.2012.488  0.243
2015 Puccetti P, Fallarino F, Italiano A, Soubeyran I, MacGrogan G, Debled M, Velasco V, Bodet D, Eimer S, Veldhoen M, Prendergast GC, Platten M, Bessede A, Guillemin GJ. Accumulation of an endogenous tryptophan-derived metabolite in colorectal and breast cancers. Plos One. 10: e0122046. PMID 25881064 DOI: 10.1371/journal.pone.0122046  0.242
2015 Wick W, Wiestler B, Platten M. Treatment of anaplastic glioma. Cancer Treatment and Research. 163: 89-101. PMID 25468227 DOI: 10.1007/978-3-319-12048-5_6  0.241
2016 Hertenstein A, Platten M, Wick W. Highlights in Central Nervous System Tumors. Jama Oncology. PMID 27658179 DOI: 10.1001/jamaoncol.2016.3673  0.241
2023 Zhao B, Kilian M, Bunse T, Platten M, Bunse L. Tumor-reactive T helper cells in the context of vaccination against glioma. Cancer Cell. 41: 1829-1834. PMID 37863064 DOI: 10.1016/j.ccell.2023.09.013  0.241
2023 Grassl N, Sahm K, Süße H, Poschke I, Bunse L, Bunse T, Boschert T, Mildenberger I, Rupp AK, Ewinger MP, Lanz LM, Denk M, Tabatabai G, Ronellenfitsch MW, Herrlinger U, ... ... Platten M, et al. INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas. Neurological Research and Practice. 5: 55. PMID 37853454 DOI: 10.1186/s42466-023-00282-4  0.24
2021 Maas SLN, Stichel D, Hielscher T, Sievers P, Berghoff AS, Schrimpf D, Sill M, Euskirchen P, Blume C, Patel A, Dogan H, Reuss D, Dohmen H, Stein M, Reinhardt A, ... ... Platten M, et al. Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2100784. PMID 34618539 DOI: 10.1200/JCO.21.00784  0.239
2009 Platten M, Vogt-Schaden M, Löw S, Bendszus M, Weller M, Wick W. Therapie primärer ZNS-Lymphome Onkopipeline. 2: 2-10. DOI: 10.1007/S15035-009-0138-Z  0.239
2013 Platten M, Steinbach JP, Wick W. [Personalized neurooncology]. Der Nervenarzt. 84: 937-42. PMID 23775285 DOI: 10.1007/s00115-013-3758-z  0.238
2017 Platten M. EGFRvIII vaccine in glioblastoma-InACT-IVe or not ReACTive enough? Neuro-Oncology. 19: 1425-1426. PMID 29059447 DOI: 10.1093/Neuonc/Nox167  0.238
2001 Roth W, Isenmann S, Nakamura M, Platten M, Wick W, Kleihues P, Bähr M, Ohgaki H, Ashkenazi A, Weller M. Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Research. 61: 2759-65. PMID 11289159  0.237
2018 Blaes J, Thomé CM, Pfenning PN, Rübmann P, Sahm F, Wick A, Bunse T, Schmenger T, Sykora J, von Deimling A, Wiestler B, Merz C, Jugold M, Haberkorn U, Abdollahi A, ... ... Platten M, et al. Inhibition of CD95/CD95L Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma. Molecular Cancer Research : McR. PMID 29453321 DOI: 10.1158/1541-7786.MCR-17-0563  0.237
2006 Platten M, Youssef S, Hur EM, Ho P, Ousman S, Sobel R, Steinman L. Sa.12. Blocking Angiotensin II Suppresses IL-12 Signaling in Autoreactive Th Cells and Treats Autoimmune Neuroinflammation Clinical Immunology. 119: S109. DOI: 10.1016/J.Clim.2006.04.244  0.234
2013 Weiler M, Pfenning PN, Thiepold AL, Blaes J, Jestaedt L, Gronych J, Dittmann LM, Berger B, Jugold M, Kosch M, Combs SE, von Deimling A, Weller M, Bendszus M, Platten M, et al. Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment. Oncogene. 32: 1099-109. PMID 22562250 DOI: 10.1038/onc.2012.137  0.232
2023 Sahm K, Kessler T, Eisele P, Ratliff M, Sperk E, König L, Breckwoldt MO, Seliger C, Mildenberger I, Schrimpf D, Herold-Mende C, Zeiner PS, Tabatabai G, Meuth SG, Capper D, ... ... Platten M, et al. Concurrent gliomas in patients with multiple sclerosis. Communications Medicine. 3: 186. PMID 38110626 DOI: 10.1038/s43856-023-00381-y  0.231
2020 Hoyer C, Stein P, Ebert A, Rausch HW, Nagel S, Eisele P, Alonso A, Platten M, Szabo K. Comparing Expert and Non-Expert Assessment of Patients Presenting with Neurological Symptoms to the Emergency Department: A Retrospective Observational Study. Neuropsychiatric Disease and Treatment. 16: 447-456. PMID 32103965 DOI: 10.2147/Ndt.S236160  0.23
2023 Kober C, Roewe J, Schmees N, Roese L, Roehn U, Bader B, Stoeckigt D, Prinz F, Gorjánácz M, Roider HG, Olesch C, Leder G, Irlbacher H, Lesche R, Lefranc J, ... ... Platten M, et al. Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy. Journal For Immunotherapy of Cancer. 11. PMID 37963637 DOI: 10.1136/jitc-2023-007495  0.229
2018 Shraibman B, Barnea E, Kadosh DM, Haimovich Y, Slobodin G, Rosner I, López-Larrea C, Hilf N, Kuttruff S, Song C, Britten C, Castle J, Kreiter S, Frenzel K, Tatagiba M, ... ... Platten M, et al. Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma. Molecular & Cellular Proteomics : McP. 17: 2132-2145. PMID 33503766 DOI: 10.1074/mcp.RA118.000792  0.229
2019 Shraibman B, Barnea E, Kadosh DM, Haimovich Y, Slobodin G, Rosner I, López-Larrea C, Hilf N, Kuttruff S, Song C, Britten C, Castle J, Kreiter S, Frenzel K, Tatagiba M, ... ... Platten M, et al. Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma. Molecular & Cellular Proteomics : McP. 18: 1255-1268. PMID 33500099 DOI: 10.1074/mcp.RA119.001524  0.229
2019 Shraibman B, Barnea E, Kadosh DM, Haimovich Y, Slobodin G, Rosner I, López-Larrea C, Hilf N, Kuttruff S, Song C, Britten C, Castle J, Kreiter S, Frenzel K, Tatagiba M, ... ... Platten M, et al. Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma. Molecular & Cellular Proteomics : McP. 18: 1255-1268. PMID 31154438 DOI: 10.1074/mcp.RA119.001524  0.229
2019 Eisele P, Baumann S, Noor L, El-Battrawy I, Ebert A, Gass A, Akin I, Kittel M, Platten M, Szabo K. Interaction between the heart and the brain in transient global amnesia. Journal of Neurology. PMID 31506826 DOI: 10.1007/S00415-019-09529-0  0.229
2011 Wick W, Weller M, Weiler M, Batchelor T, Yung AW, Platten M. Pathway inhibition: emerging molecular targets for treating glioblastoma. Neuro-Oncology. 13: 566-79. PMID 21636705 DOI: 10.1093/neuonc/nor039  0.226
2022 Bunse L, Rupp AK, Poschke I, Bunse T, Lindner K, Wick A, Blobner J, Misch M, Tabatabai G, Glas M, Schnell O, Gempt J, Denk M, Reifenberger G, Bendszus M, ... ... Platten M, et al. AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas. Neurological Research and Practice. 4: 20. PMID 35599302 DOI: 10.1186/s42466-022-00184-x  0.226
2021 Zhang XW, Huck K, Jähne K, Cichon F, Sonner JK, Ufer F, Bauer S, Woo MS, Green E, Lu K, Kilian M, Friese MA, Platten M, Sahm K. Activity-regulated cytoskeleton-associated protein/activity-regulated gene 3.1 (Arc/Arg3.1) enhances dendritic cell vaccination in experimental melanoma. Oncoimmunology. 10: 1920739. PMID 34026332 DOI: 10.1080/2162402X.2021.1920739  0.226
2016 Diem R, Molnar F, Beisse F, Gross N, Drüschler K, Heinrich SP, Joachimsen L, Rauer S, Pielen A, Sühs KW, Linker RA, Huchzermeyer C, Albrecht P, Hassenstein A, Aktas O, ... ... Platten M, et al. Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol. Bmj Open. 6: e010956. PMID 26932144 DOI: 10.1136/Bmjopen-2015-010956  0.226
2014 Wick W, Wick A, Platten M. Good maths is needed to understand CMV data in glioblastoma. International Journal of Cancer. Journal International Du Cancer. 134: 2991-2. PMID 24248554 DOI: 10.1002/Ijc.28614  0.225
2019 Hoyer C, Stein P, Alonso A, Platten M, Szabo K. Uncompleted emergency department care and discharge against medical advice in patients with neurological complaints: a chart review. Bmc Emergency Medicine. 19: 52. PMID 31601187 DOI: 10.1186/S12873-019-0273-Y  0.225
2021 Platten M, Friedrich M, Wainwright DA, Panitz V, Opitz CA. Tryptophan metabolism in brain tumors - IDO and beyond. Current Opinion in Immunology. 70: 57-66. PMID 33813026 DOI: 10.1016/j.coi.2021.03.005  0.224
2019 Shraibman B, Barnea E, Kadosh DM, Haimovich Y, Slobodin G, Rosner I, López-Larrea C, Hilf N, Kuttruff S, Song C, Britten C, Castle J, Kreiter S, Frenzel K, Tatagiba M, ... ... Platten M, et al. Withdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma. Molecular & Cellular Proteomics : McP. 18: 1270. PMID 33500100 DOI: 10.1074/mcp.W119.001571  0.224
2017 Hoyer C, Alonso A, Schlotter-Weigel B, Platten M, Fatar M. HIV-Associated Cerebellar Dysfunction and Improvement with Aminopyridine Therapy: A Case Report. Case Reports in Neurology. 9: 121-126. PMID 28626409 DOI: 10.1159/000475544  0.223
2014 Schumacher T, Bunse L, Pusch S, Sahm F, von Deimling A, Wick W, Platten M. Mutant IDH1R132H bears a mutation-specific CD4 T cell epitope suitable for vaccination of human CNS tumors Journal of Neuroimmunology. 275: 39. DOI: 10.1016/j.jneuroim.2014.08.104  0.223
2016 Platten M, Bunse L, Wick W, Bunse T. Concepts in glioma immunotherapy. Cancer Immunology, Immunotherapy : Cii. PMID 27460064 DOI: 10.1007/s00262-016-1874-x  0.223
2010 Wick A, Schäfer N, Dörner N, Schemmer D, Platten M, Bendszus M, Wick W. Arterial hypertension and bevacizumab treatment in glioblastoma: no correlation with clinical outcome. Journal of Neuro-Oncology. 97: 157-8. PMID 19727565 DOI: 10.1007/S11060-009-0003-5  0.222
2020 Hoyer C, Ebert A, Pooyeh A, Eisele P, Gass A, Platten M, Szabo K. Shedding light on the clinical recognition process of transient global amnesia. European Journal of Neurology. PMID 32484252 DOI: 10.1111/Ene.14371  0.222
2007 Wick W, Platten M. Brain tumor-related edema Rivista Medica. 13: 197-200.  0.222
2015 Sahm F, Schrimpf D, Jones DT, Meyer J, Kratz A, Reuss D, Capper D, Koelsche C, Korshunov A, Wiestler B, Buchhalter I, Milde T, Selt F, Sturm D, Kool M, ... ... Platten M, et al. Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets. Acta Neuropathologica. PMID 26671409 DOI: 10.1007/S00401-015-1519-8  0.221
2013 Wick W, Meisner C, Hentschel B, Platten M, Schilling A, Wiestler B, Sabel MC, Koeppen S, Ketter R, Weiler M, Tabatabai G, von Deimling A, Gramatzki D, Westphal M, Schackert G, et al. Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation. Neurology. 81: 1515-22. PMID 24068788 DOI: 10.1212/Wnl.0B013E3182A95680  0.221
2013 Wiestler B, Claus R, Hartlieb SA, Schliesser MG, Weiss EK, Hielscher T, Platten M, Dittmann LM, Meisner C, Felsberg J, Happold C, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, et al. Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective. Neuro-Oncology. 15: 1017-26. PMID 23595628 DOI: 10.1093/Neuonc/Not043  0.22
2021 Singh K, Batich KA, Wen PY, Tan AC, Bagley SJ, Lim M, Platten M, Colman H, Ashley DM, Chang SM, Rahman R, Galanis E, Mansouri A, Puduvalli VK, Reardon DA, et al. Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34561270 DOI: 10.1158/1078-0432.CCR-21-2681  0.219
2018 Rabe JH, Sammour DA, Schulz S, Munteanu B, Ott M, Ochs K, Hohenberger P, Marx A, Platten M, Opitz CA, Ory DS, Hopf C. Author Correction: Fourier Transform Infrared Microscopy Enables Guidance of Automated Mass Spectrometry Imaging to Predefined Tissue Morphologies. Scientific Reports. 8: 6361. PMID 29670167 DOI: 10.1038/S41598-018-24807-Z  0.217
2018 Kessler T, Wick A, Platten M, Meisner C, Bamberg M, Herrlinger U, Felsberg J, Weyerbrock A, Seidel C, Steinbach J, Sabel M, Vesper J, Debus J, Sahm F, Meixensberger J, et al. ACTR-61. LONG-TERM ANALYSES OF THE NOA-08 RANDOMIZED PHASE III TRIAL Neuro-Oncology. 20: vi25-vi25. DOI: 10.1093/Neuonc/Noy148.091  0.217
2010 Bendszus M, Platten M. [Neuroradiological response criteria for malignant gliomas]. Der Nervenarzt. 81: 950-5. PMID 20669003 DOI: 10.1007/s00115-010-2959-y  0.217
2016 Sahm F, Ochs K, Bunse L, Barnea E, Trautwein N, Weller M, Deimling A, Admon A, Wick W, Platten M. OS2.4 Expression and relevance of tumoral and stromal MHC class II in gliomas Neuro-Oncology. 18: iv5-iv5. DOI: 10.1093/NEUONC/NOW188.014  0.216
2009 Seidel C, Wick A, Platten M, Wick W. Neuroonkologie bei älteren Patienten Nervenheilkunde. 28: 304-309. DOI: 10.1055/S-0038-1628632  0.216
2016 Platten M, Schilling D, Bunse T, Sahm F, Hueckelhoven A, Schenkel I, Stevanovic S, Schmitt A, Laumann M, Steinbach JP, Misch M, Tabatabai G, Weyerbrock A, Schnell O, Krex D, et al. A mutation-specific peptide vaccine targeting IDH1R132H in patients with newly diagnosed malignant astrocytomas: A first-in-man multicenter phase I clinical trial of the German Neurooncology Working Group (NOA-16). Journal of Clinical Oncology. 34: TPS2082-TPS2082. DOI: 10.1200/Jco.2016.34.15_Suppl.Tps2082  0.216
2018 Hilf N, Kuttruff-Coqui S, Frenzel K, Bukur V, Stevanović S, Gouttefangeas C, Platten M, Tabatabai G, Dutoit V, van der Burg SH, Thor Straten P, Martínez-Ricarte F, Ponsati B, Okada H, Lassen U, et al. Actively personalized vaccination trial for newly diagnosed glioblastoma. Nature. PMID 30568303 DOI: 10.1038/S41586-018-0810-Y  0.215
2015 Ott M, Litzenburger UM, Rauschenbach KJ, Bunse L, Ochs K, Sahm F, Pusch S, Opitz CA, Blaes J, von Deimling A, Wick W, Platten M. Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway. Glia. 63: 78-90. PMID 25132599 DOI: 10.1002/glia.22734  0.214
2018 Wolf ME, Rausch HW, Eisele P, Habich S, Platten M, Alonso A. Acute Corticonuclear Tract Ischemic Stroke with Isolated Central Facial Palsy. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. PMID 30446207 DOI: 10.1016/J.Jstrokecerebrovasdis.2018.10.030  0.214
2014 Weiler M, Blaes J, Pusch S, Sahm F, Czabanka M, Luger S, Bunse L, Solecki G, Eichwald V, Jugold M, Hodecker S, Osswald M, Meisner C, Hielscher T, Rübmann P, ... ... Platten M, et al. mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy. Proceedings of the National Academy of Sciences of the United States of America. 111: 409-14. PMID 24367102 DOI: 10.1073/Pnas.1314469111  0.213
2011 Wong DD, Spagnolo DV, Bisceglia M, Havlat M, McCallum D, Platten MA. Oncocytic adrenocortical neoplasms--a clinicopathologic study of 13 new cases emphasizing the importance of their recognition. Human Pathology. 42: 489-99. PMID 21237489 DOI: 10.1016/j.humpath.2010.08.010  0.211
2007 Platten M, Opitz CA, Kohlhof P, Hegenbart U, Ho AD, Wick W. Painful neuropathy due to intraneural leukemic spread in a patient with acute myeloid leukemia. Neurology. 69: 707. PMID 17698797 DOI: 10.1212/01.Wnl.0000275547.39894.A6  0.211
2014 Vacchelli E, Aranda F, Eggermont A, Sautès-Fridman C, Tartour E, Kennedy EP, Platten M, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology. 3: e957994. PMID 25941578 DOI: 10.4161/21624011.2014.957994  0.21
2020 Kessler T, Berberich A, Sadik A, Sahm F, Gorlia T, Meisner C, Hoffmann DC, Wick A, Kickingereder P, Rübmann P, Bendszus M, Opitz C, Weller M, van den Bent M, Stupp R, ... ... Platten M, et al. Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes. Cancer Medicine. PMID 32991787 DOI: 10.1002/cam4.3447  0.209
2020 Hoyer C, Ebert A, Huttner HB, Puetz V, Kallmünzer B, Barlinn K, Haverkamp C, Harloff A, Brich J, Platten M, Szabo K. Acute Stroke in Times of the COVID-19 Pandemic: A Multicenter Study. Stroke. 51: 2224-2227. PMID 32516064 DOI: 10.1161/Strokeaha.120.030395  0.209
2014 Wiestler B, Radbruch A, Osswald M, Combs SE, Jungk C, Winkler F, Bendszus M, Unterberg A, Platten M, Wick W, Wick A. Towards optimizing the sequence of bevacizumab and nitrosoureas in recurrent malignant glioma. Journal of Neuro-Oncology. 117: 85-92. PMID 24458956 DOI: 10.1007/s11060-013-1356-3  0.208
2009 Stewart CJ, Crook ML, Leung YC, Platten M. Expression of cell cycle regulatory proteins in endometrial adenocarcinoma: variations in conventional tumor areas and in microcystic, elongated and fragmented glands. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 22: 725-33. PMID 19270644 DOI: 10.1038/modpathol.2009.33  0.208
2013 Ochs K, Sahm F, Opitz CA, Lanz TV, Oezen I, Couraud PO, von Deimling A, Wick W, Platten M. Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant glioma. Journal of Neuroimmunology. 265: 106-16. PMID 24090655 DOI: 10.1016/j.jneuroim.2013.09.011  0.207
2012 Wick W, Meisner C, Platten M, Simon M, Nikkhah G, Papsdorf K, Sabel M, Braun C, Reifenberger G, Weller M. MGMT promoter methylation as a predictive biomarker for response to radiotherapy versus chemotherapy in malignant astrocytomas in the elderly: The NOA-08 trial. Journal of Clinical Oncology. 30: 2000-2000. DOI: 10.1200/Jco.2012.30.15_Suppl.2000  0.206
2022 Ratliff M, Kim H, Qi H, Kim M, Ku B, Azorin DD, Hausmann D, Khajuria RK, Patel A, Maier E, Cousin L, Ogier A, Sahm F, Etminan N, Bunse L, ... ... Platten M, et al. Patient-Derived Tumor Organoids for Guidance of Personalized Drug Therapies in Recurrent Glioblastoma. International Journal of Molecular Sciences. 23. PMID 35743016 DOI: 10.3390/ijms23126572  0.206
2014 Schumacher T, Bunse L, Pusch S, Sahm F, Wiestler B, Quandt J, Menn O, Osswald M, Oezen I, Ott M, Keil M, Balß J, Rauschenbach K, Grabowska AK, Vogler I, ... ... Platten M, et al. A vaccine targeting mutant IDH1 induces antitumour immunity. Nature. 512: 324-7. PMID 25043048 DOI: 10.1038/nature13387  0.206
2020 Kessler T, Berberich A, Casalini B, Drüschler K, Ostermann H, Dormann A, Walter S, Hai L, Schlesner M, Herold-Mende C, Jungk C, Unterberg A, Bendszus M, Sahm K, von Deimling A, ... ... Platten M, et al. Molecular profiling-based decision for targeted therapies in wild-type glioblastoma. Neuro-Oncology Advances. 2: vdz060. PMID 32642725 DOI: 10.1093/noajnl/vdz060  0.203
2019 van Tilburg CM, Witt R, Pajtler KW, Christoph P, Poschke I, Platten M, Harting I, Sedlaczek O, Freitag A, Meyrath D, Taylor L, Balasubramanian GP, Jäger N, Pfaff E, Worst BC, et al. INFORM2 exploratory multinational phase I/II combination study of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies: INFORM2 NivEnt. Journal of Clinical Oncology. 37: TPS10065-TPS10065. DOI: 10.1200/Jco.2019.37.15_Suppl.Tps10065  0.202
2019 Platten M. Practice-changing developments in neuro-oncology: embracing heterogeneity. Therapeutic Advances in Neurological Disorders. 12: 1756286419827688. PMID 30792819 DOI: 10.1177/1756286419827688  0.2
2019 Bunse L, Green EW, Platten M. High-throughput discovery of cancer-targeting TCRs. Methods in Enzymology. 629: 401-417. PMID 31727251 DOI: 10.1016/Bs.Mie.2019.10.009  0.199
2017 Thomé C, Blaes J, Rübmann P, Hertenstein A, Kessler T, Sonner J, Deumelandt K, Breckwoldt M, Platten M, Wick W. P01.32 NDRG1 induced downregulation of CCL2 influences the migration of macrophages and impacts the tumor microenvironement Neuro-Oncology. 19: iii30-iii30. DOI: 10.1093/NEUONC/NOX036.108  0.199
2020 Hoyer C, Ebert A, Szabo K, Platten M, Meyer-Lindenberg A, Kranaster L. Decreased utilization of mental health emergency service during the COVID-19 pandemic. European Archives of Psychiatry and Clinical Neuroscience. PMID 32519205 DOI: 10.1007/S00406-020-01151-W  0.198
2019 Berberich A, Bartels F, Tang Z, Pusch S, Hucke N, Kessler T, Dong Z, Wiestler B, Winkler F, Platten M, Wick W, Abdollahi A, Lemke D. P11.07 LAPTM5 functions as a tumor suppressor via CD40 - NFêB pathway inhibition and represents a potential biomarker for temozolomide sensitivity in CD40 proficient glioblastoma Neuro-Oncology. 21: iii43-iii43. DOI: 10.1093/neuonc/noz126.153  0.198
2014 Wick W, Weller M, van den Bent M, Sanson M, Weiler M, von Deimling A, Plass C, Hegi M, Platten M, Reifenberger G. MGMT testing--the challenges for biomarker-based glioma treatment. Nature Reviews. Neurology. 10: 372-85. PMID 24912512 DOI: 10.1038/Nrneurol.2014.100  0.196
2010 Berger B, Capper D, Lemke D, Pfenning PN, Platten M, Weller M, von Deimling A, Wick W, Weiler M. Defective p53 antiangiogenic signaling in glioblastoma. Neuro-Oncology. 12: 894-907. PMID 20504876 DOI: 10.1093/neuonc/noq051  0.195
2013 Sahm F, Oezen I, Opitz CA, Radlwimmer B, von Deimling A, Ahrendt T, Adams S, Bode HB, Guillemin GJ, Wick W, Platten M. The endogenous tryptophan metabolite and NAD+ precursor quinolinic acid confers resistance of gliomas to oxidative stress. Cancer Research. 73: 3225-34. PMID 23548271 DOI: 10.1158/0008-5472.CAN-12-3831  0.192
2010 Lanz TV, Opitz CA, Ho PP, Agrawal A, Lutz C, Weller M, Mellor AL, Steinman L, Wick W, Platten M. Mouse mesenchymal stem cells suppress antigen-specific TH cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1). Stem Cells and Development. 19: 657-68. PMID 19886804 DOI: 10.1089/Scd.2009.0385  0.191
2021 Friedrich M, Kehl N, Engelke N, Kraus J, Lindner K, Münch P, Mildenberger I, Groden C, Gass A, Etminan N, Fatar M, von Deimling A, Reuss D, Platten M, Bunse L. Intrathecal activation of CD8 memory T cells in IgG4-related disease of the brain parenchyma. Embo Molecular Medicine. e13953. PMID 34254741 DOI: 10.15252/emmm.202113953  0.19
2016 Deumelandt KL, Bunse T, Bunse L, Sonner JK, Thomé C, Nadji-Ohl M, Wick W, Platten M. P04.04 Ex vivo expansion of human glioma-infiltrating lymphocytes alters the exhaustion phenotype of T cells Neuro-Oncology. 18: iv24-iv24. DOI: 10.1093/NEUONC/NOW188.082  0.19
2018 Wick W, Platten M. Understanding and Treating Glioblastoma. Neurologic Clinics. 36: 485-499. PMID 30072067 DOI: 10.1016/j.ncl.2018.04.006  0.19
2022 Lu KH, Michel J, Kilian M, Aslan K, Qi H, Kehl N, Jung S, Sanghvi K, Lindner K, Zhang XW, Green EW, Poschke I, Ratliff M, Bunse T, Sahm F, ... ... Platten M, et al. T cell receptor dynamic and transcriptional determinants of T cell expansion in glioma-infiltrating T cells. Neuro-Oncology Advances. 4: vdac140. PMID 36196364 DOI: 10.1093/noajnl/vdac140  0.188
2016 Wick W, Hertenstein A, Platten M. Neurological sequelae of cancer immunotherapies and targeted therapies. The Lancet. Oncology. 17: e529-e541. PMID 27924751 DOI: 10.1016/S1470-2045(16)30571-X  0.186
2012 Platten M, Litzenburger U, Wick W. The aryl hydrocarbon receptor in tumor immunity. Oncoimmunology. 1: 396-397. PMID 22737628 DOI: 10.4161/onci.19071  0.184
2016 Keil M, Sonner JK, Lanz TV, Oezen I, Bunse T, Bittner S, Meyer HV, Meuth SG, Wick W, Platten M. General control non-derepressible 2 (GCN2) in T cells controls disease progression of autoimmune neuroinflammation. Journal of Neuroimmunology. 297: 117-26. PMID 27397084 DOI: 10.1016/j.jneuroim.2016.05.014  0.183
2001 Weller M, Wick W, Platten M. Role of TGF-beta in oncogenesis. Microscopy Research and Technique. 52: 353. PMID 11170293 DOI: 10.1002/1097-0029(20010215)52:4<353::Aid-Jemt1019>3.0.Co;2-U  0.183
2020 Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G, Bendszus M, Balana C, Chinot O, Dirven L, French P, Hegi ME, Jakola AS, Platten M, Roth P, et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nature Reviews. Clinical Oncology. PMID 33293629 DOI: 10.1038/s41571-020-00447-z  0.181
2017 Pusch S, Krausert S, Fischer V, Balss J, Ott M, Schrimpf D, Capper D, Sahm F, Eisel J, Beck AC, Jugold M, Eichwald V, Kaulfuss S, Panknin O, Rehwinkel H, ... ... Platten M, et al. Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo. Acta Neuropathologica. PMID 28124097 DOI: 10.1007/s00401-017-1677-y  0.181
2024 Meyer M, Parpoulas C, Barthélémy T, Becker JP, Charoentong P, Lyu Y, Börsig S, Bulbuc N, Tessmer C, Weinacht L, Ibberson D, Schmidt P, Pipkorn R, Eichmüller SB, Steinberger P, ... ... Platten M, et al. MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection. Frontiers in Immunology. 14: 1294565. PMID 38239352 DOI: 10.3389/fimmu.2023.1294565  0.18
2016 Hertenstein A, Hielscher T, Menn O, Wiestler B, Winkler F, Platten M, Wick W, Wick A. Impact of tapering and discontinuation of bevacizumab in patients with progressive glioblastoma. Journal of Neuro-Oncology. PMID 27422128 DOI: 10.1007/s11060-016-2206-x  0.178
2017 Bunse L, Bunse T, Sanghvi K, Green E, Sahm F, Omokoko T, Sahin U, Schmitt M, Wick W, Platten M. OS09.9 Identification of IDH1R132H-specific T cell receptors from glioma patients and from MHC-humanized mice Neuro-Oncology. 19: iii20-iii20. DOI: 10.1093/Neuonc/Nox036.068  0.176
2022 Bunse L, Sommerer C, Tan CL, Korell F, Schmitt A, Hückelhoven-Krauss A, Neuber B, Mertens T, Platten M, Green EW, Zeier M, Schmitt M. Common T-Cell-Receptor Motifs and Features in Patients with Cytomegalovirus (CMV)-Seronegative End-Stage Renal Disease Receiving a Peptide Vaccination against CMV. International Journal of Molecular Sciences. 23. PMID 35162953 DOI: 10.3390/ijms23031029  0.175
2017 Sahm F, Schrimpf D, Stichel D, Jones DT, Hielscher T, Schefzyk S, Okonechnikov K, Koelsche C, Reuss DE, Capper D, Sturm D, Wirsching HG, Berghoff AS, Baumgarten P, Kratz A, ... ... Platten M, et al. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. The Lancet. Oncology. PMID 28314689 DOI: 10.1016/S1470-2045(17)30155-9  0.175
2021 Jayachandran Preetha C, Meredig H, Brugnara G, Mahmutoglu MA, Foltyn M, Isensee F, Kessler T, Pflüger I, Schell M, Neuberger U, Petersen J, Wick A, Heiland S, Debus J, Platten M, et al. Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study. The Lancet. Digital Health. PMID 34688602 DOI: 10.1016/S2589-7500(21)00205-3  0.175
2022 Eisele P, Wittayer M, Weber CE, Platten M, Schirmer L, Gass A. Impact of disease-modifying therapies on evolving tissue damage in iron rim multiple sclerosis lesions. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221106338. PMID 35778799 DOI: 10.1177/13524585221106338  0.175
2017 Nowosielski M, Ellingson BM, Chinot OL, Garcia J, Revil C, Radbruch A, Nishikawa R, Mason WP, Henriksson R, Saran F, Kickingereder P, Platten M, Sandmann T, Abrey LE, Cloughesy TF, et al. Radiologic progression of glioblastoma under therapy - an exploratory analysis of AVAglio. Neuro-Oncology. PMID 29016943 DOI: 10.1093/neuonc/nox162  0.173
2019 Green EW, Bunse L, Bozza M, Sanghvi K, Platten M. TCR validation toward gene therapy for cancer. Methods in Enzymology. 629: 419-441. PMID 31727252 DOI: 10.1016/Bs.Mie.2019.10.010  0.169
2009 Wick W, Platten M, Weller M. New (alternative) temozolomide regimens for the treatment of glioma. Neuro-Oncology. 11: 69-79. PMID 18772354 DOI: 10.1215/15228517-2008-078  0.168
2023 Winkler F, Venkatesh HS, Amit M, Batchelor T, Demir IE, Deneen B, Gutmann DH, Hervey-Jumper S, Kuner T, Mabbott D, Platten M, Rolls A, Sloan EK, Wang TC, Wick W, et al. Cancer neuroscience: State of the field, emerging directions. Cell. 186: 1689-1707. PMID 37059069 DOI: 10.1016/j.cell.2023.02.002  0.167
2023 Kessler T, Schrimpf D, Doerner L, Hai L, Kaulen LD, Ito J, van den Bent M, Taphoorn M, Brandes AA, Idbaih A, Dômont J, Clement PM, Campone M, Bendszus M, von Deimling A, ... ... Platten M, et al. Prognostic markers of DNA methylation and NGS sequencing in progressive glioblastoma from the EORTC-26101 trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 37494539 DOI: 10.1158/1078-0432.CCR-23-0926  0.166
2016 Lemke D, Pledl HW, Zorn M, Jugold M, Green E, Blaes J, Löw S, Hertenstein A, Ott M, Sahm F, Steffen AC, Weiler M, Winkler F, Platten M, Dong Z, et al. Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapy. Oncotarget. PMID 27447560 DOI: 10.18632/Oncotarget.10723  0.164
2012 Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, Sabel M, Combs SE, Vesper J, Braun C, Meixensberger J, Ketter R, et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. The Lancet. Oncology. 13: 707-15. PMID 22578793 DOI: 10.1016/S1470-2045(12)70164-X  0.162
2021 Tan AC, Bagley SJ, Wen PY, Lim M, Platten M, Colman H, Ashley DM, Wick W, Chang SM, Galanis E, Mansouri A, Khagi S, Mehta MP, Heimberger AB, Puduvalli VK, et al. Systematic review of combinations of targeted or immunotherapy in advanced solid tumors. Journal For Immunotherapy of Cancer. 9. PMID 34215688 DOI: 10.1136/jitc-2021-002459  0.162
2015 Osswald M, Jung E, Sahm F, Solecki G, Venkataramani V, Blaes J, Weil S, Horstmann H, Wiestler B, Syed M, Huang L, Ratliff M, Karimian Jazi K, Kurz FT, Schmenger T, ... ... Platten M, et al. Brain tumour cells interconnect to a functional and resistant network. Nature. PMID 26536111 DOI: 10.1038/nature16071  0.16
2020 Ouellette R, Mangeat G, Polyak I, Warntjes M, Forslin Y, Bergendal Å, Plattén M, Uppman M, Treaba CA, Cohen-Adad J, Piehl F, Wiberg MK, Fredrikson S, Mainero C, Granberg T. Validation of rapid magnetic resonance myelin imaging in multiple sclerosis. Annals of Neurology. PMID 32057118 DOI: 10.1002/Ana.25705  0.159
2014 Keil M, Paulsen M, Sonner J, Wanke F, Oezen I, Schumacher T, Okun JG, Kurschuss F, Reinhardt C, Rosenstiel P, Wick W, Platten M. Dietary tryptophan is required for CNS infiltration of encephalitogenic T cells Journal of Neuroimmunology. 275: 156. DOI: 10.1016/J.JNEUROIM.2014.08.418  0.156
2021 Mickeviciute GC, Valiuskyte M, Plattén M, Wszolek ZK, Andersen O, Danylaité Karrenbauer V, Ineichen BV, Granberg T. Neuroimaging phenotypes of CSF1R-related leukoencephalopathy: Systematic review, meta-analysis, and imaging recommendations. Journal of Internal Medicine. PMID 34875121 DOI: 10.1111/joim.13420  0.156
2016 Bunse T, Bunse L, Sahm F, Omokoko T, Stevanovic S, Deimling A, Sahin U, Schmitt M, Wick W, Platten M. OS2.1 Immune responses to a mutation-specific peptide vaccine targeting IDH1R132H in patients with IDH1R132H-mutated gliomas Neuro-Oncology. 18: iv4-iv4. DOI: 10.1093/NEUONC/NOW188.011  0.155
2016 Hertenstein A, Jones D, Sahm F, Pfaff E, Hutter B, Karapanagiotou-Schenkel I, Eisenmenger A, Osswald M, Wick A, Loew S, Bendszus M, Debus J, Herold-Mende C, Unterberg A, von Deimling A, ... ... Platten M, et al. Umbrella protocol for phase I/IIa trials of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed glioblastoma without MGMT promoter methylation Neuro Master Match (N²M²). Journal of Clinical Oncology. 34: TPS2084-TPS2084. DOI: 10.1200/JCO.2016.34.15_SUPPL.TPS2084  0.153
2021 Weber CE, Krämer J, Wittayer M, Gregori J, Randoll S, Weiler F, Heldmann S, Roßmanith C, Platten M, Gass A, Eisele P. Association of iron rim lesions with brain and cervical cord volume in relapsing multiple sclerosis. European Radiology. PMID 34549326 DOI: 10.1007/s00330-021-08233-w  0.153
2011 Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, Schumacher T, Jestaedt L, Schrenk D, Weller M, Jugold M, Guillemin GJ, Miller CL, Lutz C, Radlwimmer B, ... ... Platten M, et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature. 478: 197-203. PMID 21976023 DOI: 10.1038/nature10491  0.152
2022 Wenzel N, Wittayer M, Weber CE, Platten M, Gass A, Eisele P. Multiple sclerosis iron rim lesions are linked to impaired cervical spinal cord integrity using the T1/T2-weighted ratio. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 36504270 DOI: 10.1111/jon.13076  0.152
2015 Platten M, Offringa R. Cancer immunotherapy: exploiting neoepitopes. Cell Research. 25: 887-8. PMID 26032267 DOI: 10.1038/cr.2015.66  0.15
2001 Wick W, Platten M, Weller M. Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta. Journal of Neuro-Oncology. 53: 177-85. PMID 11716069 DOI: 10.1023/A:1012209518843  0.146
2022 Epping L, Schroeter CB, Nelke C, Bock S, Gola L, Ritter N, Herrmann AM, Räuber S, Henes A, Wasser B, Fernandez-Orth J, Neuhaus W, Bittner S, Budde T, Platten M, et al. Activation of non-classical NMDA receptors by glycine impairs barrier function of brain endothelial cells. Cellular and Molecular Life Sciences : Cmls. 79: 479. PMID 35951110 DOI: 10.1007/s00018-022-04502-z  0.145
2014 Wick W, Platten M. Understanding and targeting alkylator resistance in glioblastoma. Cancer Discovery. 4: 1120-2. PMID 25274683 DOI: 10.1158/2159-8290.CD-14-0918  0.145
2013 Leslie C, Shingde M, Kwok F, Platten M, Tesfai Y, Amanuel B, Spagnolo DV. T-lymphoblastic proliferation and florid multifocal follicular dendritic cell proliferation occurring in hyaline-vascular Castleman disease in a patient with a possible familial predisposition Journal of Hematopathology. 6: 237-244. DOI: 10.1007/s12308-013-0184-x  0.144
2001 Platten M, Wick W, Weller M. Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape. Microscopy Research and Technique. 52: 401-10. PMID 11170299 DOI: 10.1002/1097-0029(20010215)52:4<401::AID-JEMT1025>3.0.CO;2-C  0.144
2021 Weber CE, Nagel K, Ebert A, Roßmanith C, Paschke N, Adlung A, Platten M, Schad LR, Gass A, Eisele P. Diffusely appearing white matter in multiple sclerosis: Insights from sodium (Na) MRI. Multiple Sclerosis and Related Disorders. 49: 102752. PMID 33486402 DOI: 10.1016/j.msard.2021.102752  0.143
2022 Wenzel N, Wittayer M, Weber CE, Schirmer L, Platten M, Gass A, Eisele P. MRI predictors for the conversion from contrast-enhancing to iron rim multiple sclerosis lesions. Journal of Neurology. PMID 35332392 DOI: 10.1007/s00415-022-11082-2  0.143
2023 Nold AK, Wittayer M, Weber CE, Platten M, Gass A, Eisele P. Short-term brain atrophy evolution after initiation of immunotherapy in a real-world multiple sclerosis cohort. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 37491626 DOI: 10.1111/jon.13146  0.143
2009 Opitz CA, Litzenburger UM, Lutz C, Lanz TV, Tritschler I, Köppel A, Tolosa E, Hoberg M, Anderl J, Aicher WK, Weller M, Wick W, Platten M. Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R. Stem Cells (Dayton, Ohio). 27: 909-19. PMID 19353519 DOI: 10.1002/stem.7  0.141
2015 Weller M, Tabatabai G, Kästner B, Felsberg J, Steinbach JP, Wick A, Schnell O, Hau P, Herrlinger U, Sabel MC, Wirsching HG, Ketter R, Bähr O, Platten M, Tonn JC, et al. MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 2057-64. PMID 25655102 DOI: 10.1158/1078-0432.Ccr-14-2737  0.14
2008 Creaney J, Segal A, Sterrett G, Platten MA, Baker E, Murch AR, Nowak AK, Robinson BW, Millward MJ. Overexpression and altered glycosylation of MUC1 in malignant mesothelioma. British Journal of Cancer. 98: 1562-9. PMID 18454162 DOI: 10.1038/sj.bjc.6604340  0.14
2015 Silginer M, Burghardt I, Gramatzki D, Bunse L, Leske H, Rushing EJ, Hao N, Platten M, Weller M, Roth P. The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway. Oncogene. PMID 26500056 DOI: 10.1038/Onc.2015.387  0.14
2016 Wick W, Brandes AA, Gorlia T, Bendszus M, Sahm F, Taal W, Taphoorn MJ, Domont J, Idbaih A, Campone M, Clement PM, Stupp R, Fabbro M, Le Rhun E, Dubois F, ... ... Platten M, et al. EORTC 26101 phase III trial exploring the combination of bevacizumab and lomustine in patients with first progression of a glioblastoma. Journal of Clinical Oncology. 34: 2001-2001. DOI: 10.1200/JCO.2016.34.15_SUPPL.2001  0.139
2005 Koay MH, Goh YW, Iacopetta B, Grieu F, Segal A, Sterrett GF, Platten M, Spagnolo DV. Gastrointestinal stromal tumours (GISTs): a clinicopathological and molecular study of 66 cases. Pathology. 37: 22-31. PMID 15875730 DOI: 10.1080/00313020400023628  0.139
2021 Grudzenski S, Heger S, de Jonge A, Schipp J, Dumont E, Larrat B, Schad L, Platten M, Fatar M. Simulation, Implementation and Measurement of Defined Sound Fields for Blood-Brain Barrier Opening in Rats. Ultrasound in Medicine & Biology. PMID 34863589 DOI: 10.1016/j.ultrasmedbio.2021.10.003  0.139
2023 Hofmann A, Krajnc N, Dal-Bianco A, Riedl CJ, Zrzavy T, Lerma-Martin C, Kasprian G, Weber CE, Pezzini F, Leutmezer F, Rommer P, Bsteh G, Platten M, Gass A, Berger T, et al. Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis. Acta Neuropathologica. 146: 707-724. PMID 37715818 DOI: 10.1007/s00401-023-02627-4  0.139
2023 Bayas A, Berthele A, Blank N, Dreger P, Faissner S, Friese MA, Gerdes LA, Grauer OM, Häussler V, Heesen C, Janson D, Korporal-Kuhnke M, Kowarik M, Kröger N, Lünemann JD, ... ... Platten M, et al. Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline. Therapeutic Advances in Neurological Disorders. 16: 17562864231180730. PMID 37780055 DOI: 10.1177/17562864231180730  0.137
2002 Ernemann U, Skalej M, Hermisson M, Platten M, Jaffe R, Voigt K. Primary cerebral non-Langerhans cell histiocytosis: MRI and differential diagnosis. Neuroradiology. 44: 759-63. PMID 12221448 DOI: 10.1007/s00234-002-0819-6  0.136
2022 Wittayer M, Hoyer C, Roßmanith C, Platten M, Gass A, Szabo K. Hippocampal subfield involvement in patients with transient global amnesia. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 35106877 DOI: 10.1111/jon.12973  0.136
2022 Wittayer M, Weber CE, Krämer J, Platten M, Schirmer L, Gass A, Eisele P. Exploring (peri-) lesional and structural connectivity tissue damage through T1/T2-weighted ratio in iron rim multiple sclerosis lesions. Magnetic Resonance Imaging. 95: 12-18. PMID 36270415 DOI: 10.1016/j.mri.2022.10.009  0.134
2017 Tykocinski LO, Lauffer AM, Bohnen A, Kaul NC, Krienke S, Tretter T, Adam I, Mohapatra SR, Saikali P, Löhning M, Neidhart M, Gay S, Oezen I, Platten M, Opitz CA, et al. Synovial Fibroblasts Selectively Suppress Th1 Cell Responses through IDO1-Mediated Tryptophan Catabolism. Journal of Immunology (Baltimore, Md. : 1950). PMID 28264972 DOI: 10.4049/jimmunol.1600600  0.134
2022 Caramanna I, de Kort JM, Brandes AA, Taal W, Platten M, Idbaih A, Frenel JS, Wick W, Preetha CJ, Bendszus M, Vollmuth P, Reijneveld JC, Klein M. Corticosteroids use and neurocognitive functioning in patients with recurrent glioblastoma: Evidence from European Organization for Research and Treatment of Cancer (EORTC) trial 26101. Neuro-Oncology Practice. 9: 310-316. PMID 35855458 DOI: 10.1093/nop/npac022  0.133
2021 Weber CE, Wittayer M, Kraemer M, Dabringhaus A, Platten M, Gass A, Eisele P. Quantitative MRI texture analysis in chronic active multiple sclerosis lesions. Magnetic Resonance Imaging. 79: 97-102. PMID 33771609 DOI: 10.1016/j.mri.2021.03.016  0.132
2023 Wittayer M, Weber CE, Kittel M, Platten M, Schirmer L, Tumani H, Gass A, Eisele P. Cerebrospinal fluid-related tissue damage in multiple sclerosis patients with iron rim lesions. Multiple Sclerosis (Houndmills, Basingstoke, England). 29: 549-558. PMID 37119207 DOI: 10.1177/13524585231155639  0.132
2015 Pilz C, Feyerabend T, Sonner J, Redaelli C, Peter K, Kunze A, Haas K, Esser C, Schäkel K, Wick W, Rodewald HR, Lanz TV, Platten M. Normal mast cell numbers in the tissues of AhR-deficient mice. Experimental Dermatology. PMID 26443189 DOI: 10.1111/exd.12864  0.132
2005 Platten M, Steinman L. Multiple sclerosis: trapped in deadly glue. Nature Medicine. 11: 252-3. PMID 15746934 DOI: 10.1038/Nm0305-252  0.131
2021 Bunse L, Platten M. How mutant isocitrate dehydrogenase orchestrates immune cells. Neuro-Oncology. PMID 34919146 DOI: 10.1093/neuonc/noab266  0.13
2020 Weber CE, Kraemer M, Dabringhaus A, Ebert A, Platten M, Gass A, Eisele P. Venous Diameter Changes in Chronic Active Multiple Sclerosis Lesions. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 33270952 DOI: 10.1111/jon.12818  0.128
2022 Le Rhun E, Oppong FB, van den Bent M, Wick W, Brandes AA, Taphoorn MJ, Platten M, Idbaih A, Clement PM, Preusser M, Golfinopoulos V, Gorlia T, Weller M. Thrombocytopenia limits the feasibility of salvage lomustine chemotherapy in recurrent glioblastoma: a secondary analysis of EORTC 26101. European Journal of Cancer (Oxford, England : 1990). 178: 13-22. PMID 36379185 DOI: 10.1016/j.ejca.2022.10.006  0.127
2024 Iser F, Hinz F, Hoffmann DC, Grassl N, Güngör C, Meyer J, Dörner L, Hofmann L, Kelbch V, Göbel K, Mahmutoglu MA, Vollmuth P, Patel A, Nguyen D, Kaulen LD, ... ... Platten M, et al. Cerebrospinal fluid cfDNA sequencing for classification of central nervous system glioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 38295147 DOI: 10.1158/1078-0432.CCR-23-2907  0.127
2014 Platten M, von Knebel Doeberitz N, Oezen I, Wick W, Ochs K. Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors. Frontiers in Immunology. 5: 673. PMID 25628622 DOI: 10.3389/fimmu.2014.00673  0.126
2022 Wittayer M, Weber CE, Platten M, Schirmer L, Gass A, Eisele P. Spatial distribution of multiple sclerosis iron rim lesions and their impact on disability. Multiple Sclerosis and Related Disorders. 64: 103967. PMID 35728430 DOI: 10.1016/j.msard.2022.103967  0.126
1998 Batchelor TT, Platten M, Hochberg FH. Immunoadsorption therapy for paraneoplastic syndromes. Journal of Neuro-Oncology. 40: 131-6. PMID 9892095 DOI: 10.1023/A:1006136219490  0.126
2015 Wong DD, de Boer WB, Platten MA, Jo VY, Cibas ES, Kumarasinghe MP. HER2 testing in malignant effusions of metastatic gastric carcinoma: is it feasible? Diagnostic Cytopathology. 43: 80-5. PMID 25363414 DOI: 10.1002/dc.23212  0.125
2001 Platten M, Wild-Bode C, Wick W, Leitlein J, Dichgans J, Weller M. N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta relesase and reduces migration and invasiveness of human malignant glioma cells. International Journal of Cancer. Journal International Du Cancer. 93: 53-61. PMID 11391621 DOI: 10.1002/ijc.1289  0.125
2007 Opitz CA, Wick W, Steinman L, Platten M. Tryptophan degradation in autoimmune diseases. Cellular and Molecular Life Sciences : Cmls. 64: 2542-63. PMID 17611712 DOI: 10.1007/S00018-007-7140-9  0.124
1989 Kennedy S, Smyth JA, Cush PF, Duignan P, Platten M, McCullough SJ, Allan GM. Histopathologic and immunocytochemical studies of distemper in seals. Veterinary Pathology. 26: 97-103. PMID 2652873 DOI: 10.1177/030098588902600201  0.124
2022 Reichl M, Wittayer M, Weber CE, Platten M, Gass A, Eisele P. Consistency of the "central vein sign" in chronic multiple sclerosis lesions. Multiple Sclerosis and Related Disorders. 58: 103530. PMID 35066270 DOI: 10.1016/j.msard.2022.103530  0.124
2015 Leslie C, Grieu-Iacopetta F, Richter A, Platten M, Murray J, Frost FA, Amanuel B, Kumarasinghe MP. BRAF p.Val600Glu (V600E) mutation detection in thyroid fine needle aspiration cell block samples: a feasibility study. Pathology. 47: 432-8. PMID 26154146 DOI: 10.1097/PAT.0000000000000273  0.123
2021 Eisele P, Kraemer M, Dabringhaus A, Weber CE, Ebert A, Platten M, Schad LR, Gass A. Characterization of chronic active multiple sclerosis lesions with sodium ( Na) MRI - preliminary observations. European Journal of Neurology. PMID 33864730 DOI: 10.1111/ene.14873  0.123
2023 Van NT, Zhang K, Wigmore RM, Kennedy AI, DaSilva CR, Huang J, Ambelil M, Villagomez JH, O'Connor GJ, Longman RS, Cao M, Snook AE, Platten M, Kasenty G, Sigal LJ, et al. Dietary L-Tryptophan consumption determines the number of colonic regulatory T cells and susceptibility to colitis via GPR15. Nature Communications. 14: 7363. PMID 37963876 DOI: 10.1038/s41467-023-43211-4  0.122
2011 Wick W, Steinbach J, Combs SE, Platten M, Hartmann C, Wenz FK, Boecker U, Stoffregen C. Enzastaurin (ENZ) before and concomitant with radiation therapy (RTX) followed by ENZ maintenance therapy in patients with newly diagnosed glioblastoma (GBM) without hypermethylation of the O6-methylguanyl DNA-methyltransferase (MGMT) promoter: A multicenter, open-label, uncontrolled phase II study. Journal of Clinical Oncology. 29: 2007-2007. DOI: 10.1200/JCO.2011.29.15_SUPPL.2007  0.121
2023 Platten M, Grassl N. Vaccines Targeting Gliomas: Antigens Matter. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2202616. PMID 36623232 DOI: 10.1200/JCO.22.02616  0.121
2004 Rankine AJ, Filion PR, Platten MA, Spagnolo DV. Perineurioma: a clinicopathological study of eight cases. Pathology. 36: 309-15. PMID 15370128 DOI: 10.1080/00313020410001721663  0.121
2018 Wick W, Wick A, Sahm F, Riehl D, von Deimling A, Bendszus M, Mickingereder P, Beckhove P, Schmitz Winnenthal F, Jungk C, Wieckoswski S, Keller A, Podola L, Herold-Mende C, Lubenau H, ... ... Platten MJ, et al. P01.031 VXM01 phase I study in patients with progressive glioblastoma - final results Neuro-Oncology. 20: iii235-iii235. DOI: 10.1093/NEUONC/NOY139.073  0.121
2022 Lanz TV, Brewer RC, Ho PP, Moon JS, Jude KM, Fernandez D, Fernandes RA, Gomez AM, Nadj GS, Bartley CM, Schubert RD, Hawes IA, Vazquez SE, Iyer M, Zuchero JB, ... ... Platten M, et al. Clonally Expanded B Cells in Multiple Sclerosis Bind EBV EBNA1 and GlialCAM. Nature. PMID 35073561 DOI: 10.1038/s41586-022-04432-7  0.121
2015 Wick W, Brandes A, Gorlia T, Bendszus M, Sahm F, Taal W, Taphoorn M, Domont J, Idbaih A, Campone M, Clement P, Stupp R, Fabbro M, Dubois F, Bais C, ... ... Platten M, et al. LB-05PHASE III TRIAL EXPLORING THE COMBINATION OF BEVACIZUMAB AND LOMUSTINE IN PATIENTS WITH FIRST RECURRENCE OF A GLIOBLASTOMA: THE EORTC 26101 TRIAL Neuro-Oncology. 17: v1.5-v1. DOI: 10.1093/NEUONC/NOV306  0.121
2024 Preusser M, Platten M, Short SC. Celebrating the 30th Anniversary of the European Association of Neuro-Oncology (EANO). Neuro-Oncology. PMID 38430930 DOI: 10.1093/neuonc/noae039  0.12
2024 Rastogi A, Brugnara G, Foltyn-Dumitru M, Mahmutoglu MA, Preetha CJ, Kobler E, Pflüger I, Schell M, Deike-Hofmann K, Kessler T, van den Bent MJ, Idbaih A, Platten M, Brandes AA, Nabors B, et al. Deep-learning-based reconstruction of undersampled MRI to reduce scan times: a multicentre, retrospective, cohort study. The Lancet. Oncology. 25: 400-410. PMID 38423052 DOI: 10.1016/S1470-2045(23)00641-1  0.12
2024 Cetin M, Pinamonti V, Schmid T, Boschert T, Mellado Fuentes A, Kromer K, Lerner T, Zhang J, Herzig Y, Ehlert C, Hernandez-Hernandez M, Samaras G, Torres CM, Fisch L, Dragan V, ... ... Platten M, et al. T-FINDER: A highly sensitive, pan-HLA platform for functional T cell receptor and ligand discovery. Science Advances. 10: eadk3060. PMID 38306432 DOI: 10.1126/sciadv.adk3060  0.12
2024 Boschert T, Kromer K, Lerner T, Lindner K, Haltenhof G, Tan CL, Jähne K, Poschke I, Bunse L, Eisele P, Grassl N, Mildenberger I, Sahm K, Platten M, Lindner JM, et al. H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patient. Science Advances. 10: eadi9091. PMID 38306431 DOI: 10.1126/sciadv.adi9091  0.12
2023 Krämer C, Kilian M, Chih YC, Kourtesakis A, Hoffmann DC, Boschert T, Koopmann P, Sanghvi K, De Roia A, Jung S, Jähne K, Day B, Shultz LD, Ratliff M, Harbottle R, ... ... Platten M, et al. NLGN4X TCR transgenic T cells to treat gliomas. Neuro-Oncology. PMID 37715782 DOI: 10.1093/neuonc/noad172  0.12
2016 Platten M, Löw S, Wick W. Meningeosis neoplastica Info Neurologie & Psychiatrie. 18: 40-50. DOI: 10.1007/s15005-016-1781-x  0.12
2020 Mangeat G, Ouellette R, Wabartha M, De Leener B, Plattén M, Danylaité Karrenbauer V, Warntjes M, Stikov N, Mainero C, Cohen-Adad J, Granberg T. Machine Learning and Multiparametric Brain MRI to Differentiate Hereditary Diffuse Leukodystrophy with Spheroids from Multiple Sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 32453488 DOI: 10.1111/Jon.12725  0.12
2016 Ochs K, Ott M, Bunse L, Sahm F, Bunse T, Deimling A, Wick W, Platten M. OS2.3 A mutation-specific vaccination approach for Histon H3.3 K27M-mutated gliomas Neuro-Oncology. 18: iv5-iv5. DOI: 10.1093/NEUONC/NOW188.013  0.118
2023 Ineichen BV, Cananau C, Plattén M, Ouellette R, Moridi T, Frauenknecht KBM, Okar SV, Kulcsar Z, Kockum I, Piehl F, Reich DS, Granberg T. Dilated Virchow-Robin spaces are a marker for arterial disease in multiple sclerosis. Ebiomedicine. 92: 104631. PMID 37253317 DOI: 10.1016/j.ebiom.2023.104631  0.117
2017 Dewi DL, Mohapatra SR, Blanco Cabañes S, Adam I, Somarribas Patterson LF, Berdel B, Kahloon M, Thürmann L, Loth S, Heilmann K, Weichenhan D, Mücke O, Heiland I, Wimberger P, Kuhlmann JD, ... ... Platten M, et al. Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer. Oncoimmunology. 6: e1274477. PMID 28344890 DOI: 10.1080/2162402X.2016.1274477  0.115
2020 van Tilburg CM, Witt R, Heiss M, Pajtler KW, Plass C, Poschke I, Platten M, Harting I, Sedlaczek O, Freitag A, Meyrath D, Taylor L, Balasubramanian GP, Jäger N, Pfaff E, et al. INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies. Bmc Cancer. 20: 523. PMID 32503469 DOI: 10.1186/S12885-020-07008-8  0.115
2015 Wong DD, Kumarasinghe MP, Platten MA, de Boer WB. Concordance of HER2 expression in paired primary and metastatic sites of gastric and gastro-oesophageal junction cancers. Pathology. PMID 26517644 DOI: 10.1097/PAT.0000000000000323  0.113
2016 Wick W, Stupp R, Gorlia T, Bendszus M, Sahm F, Bromberg JE, Brandes AA, Vos MJ, Domont J, Idbaih A, Frenel J, Clement PM, Fabbro M, Le Rhun E, Dubois F, ... ... Platten M, et al. Phase II part of EORTC study 26101: The sequence of bevacizumab and lomustine in patients with first recurrence of a glioblastoma. Journal of Clinical Oncology. 34: 2019-2019. DOI: 10.1200/JCO.2016.34.15_SUPPL.2019  0.111
2021 Wiendl H, Gold R, Berger T, Derfuss T, Linker R, Mäurer M, Stangel M, Aktas O, Baum K, Berghoff M, Bittner S, Chan A, Czaplinski A, Deisenhammer F, Di Pauli F, ... ... Platten M, et al. [Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]. Der Nervenarzt. PMID 34297142 DOI: 10.1007/s00115-021-01157-2  0.109
2021 Weber CE, Wittayer M, Kraemer M, Dabringhaus A, Bail K, Platten M, Schirmer L, Gass A, Eisele P. Long-term dynamics of multiple sclerosis iron rim lesions. Multiple Sclerosis and Related Disorders. 57: 103340. PMID 35158450 DOI: 10.1016/j.msard.2021.103340  0.108
2001 Goh YW, Spagnolo DV, Platten M, Caterina P, Fisher C, Oliveira AM, Nascimento AG. Extraskeletal myxoid chondrosarcoma: a light microscopic, immunohistochemical, ultrastructural and immuno-ultrastructural study indicating neuroendocrine differentiation. Histopathology. 39: 514-24. PMID 11737310 DOI: 10.1046/j.1365-2559.2001.01277.x  0.108
2014 Sonner J, Keil M, Lanz T, Oezen I, Schumacher T, Sahm F, Wick W, Platten M. Impaired remission from autoimmune neuroinflammation upon T cell-specific knockout of the stress kinase GCN2 Journal of Neuroimmunology. 275: 174. DOI: 10.1016/j.jneuroim.2014.08.467  0.107
2018 Nowag A, Platten M, Plum G, Hartmann P. [Nontuberculous mycobacterial infections]. Zeitschrift Fur Rheumatologie. 76: 752-760. PMID 29071482 DOI: 10.1007/s00393-017-0392-3  0.107
2013 Tykocinski L, Lauffer A, Bohnen A, Krienke S, Oezen I, Litzenburger U, Platten M, Lorenz H. A3.18 Synovial Fibroblasts Inhibit Inflammatory T Cell Responses through Tryptophan Metabolism Annals of the Rheumatic Diseases. 72: A20.1-A20. DOI: 10.1136/annrheumdis-2013-203216.18  0.107
2014 Dyke JM, Crook ML, Platten M, Stewart CJ. Extravascular migratory metastasis in gynaecological carcinosarcoma. Histopathology. 65: 363-70. PMID 24734932 DOI: 10.1111/his.12395  0.105
2022 Platten M, Ouellette R, Herranz E, Barletta V, Treaba CA, Mainero C, Granberg T. Cortical and white matter lesion topology influences focal corpus callosum atrophy in multiple sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 35165979 DOI: 10.1111/jon.12977  0.105
2021 Wiendl H, Gold R, Berger T, Derfuss T, Linker R, Mäurer M, Aktas O, Baum K, Berghoff M, Bittner S, Chan A, Czaplinski A, Deisenhammer F, Di Pauli F, Du Pasquier R, ... ... Platten M, et al. Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper). Therapeutic Advances in Neurological Disorders. 14: 17562864211039648. PMID 34422112 DOI: 10.1177/17562864211039648  0.105
2019 Platten M, Martola J, Fink K, Ouellette R, Piehl F, Granberg T. MRI-Based Manual versus Automated Corpus Callosum Volumetric Measurements in Multiple Sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 31750599 DOI: 10.1111/jon.12676  0.103
2014 Bunse L, Schumacher T, Sahm F, Pusch S, Oezen I, von Deimling A, Wick W, Platten M. In situ proximity ligation assay to evaluate presentation of a mutated CD4 epitope in human glioma tissue Journal of Neuroimmunology. 275: 35. DOI: 10.1016/j.jneuroim.2014.08.096  0.102
2021 Kleinsorge MT, Ebert A, Förster A, Weber CE, Roßmanith C, Platten M, Gass A, Eisele P. MRI topography of lesions related to internuclear ophthalmoplegia in patients with multiple sclerosis or ischemic stroke. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 31: 471-474. PMID 33793026 DOI: 10.1111/jon.12847  0.101
2023 Papaioannou S, See JX, Jeong M, De La Torre C, Ast V, Reiners-Koch PS, Sati A, Mogler C, Platten M, Cerwenka A, Stojanovic A. Liver sinusoidal endothelial cells orchestrate NK cell recruitment and activation in acute inflammatory liver injury. Cell Reports. 42: 112836. PMID 37471222 DOI: 10.1016/j.celrep.2023.112836  0.098
2022 Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G, Bendszus M, Balana C, Chinot O, Dirven L, French P, Hegi ME, Jakola AS, Platten M, Roth P, et al. Author Correction: EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nature Reviews. Clinical Oncology. PMID 35322237 DOI: 10.1038/s41571-022-00623-3  0.098
2022 Manta CP, Leibing T, Friedrich M, Nolte H, Adrian M, Schledzewski K, Krzistetzko J, Kirkamm C, David Schmid C, Xi Y, Stojanovic A, Tonack S, de la Torre C, Hammad S, Offermanns S, ... ... Platten M, et al. Targeting of Scavenger Receptors Stabilin-1 and Stabilin-2 Ameliorates Atherosclerosis by a Plasma Proteome Switch Mediating Monocyte/Macrophage Suppression. Circulation. PMID 36325910 DOI: 10.1161/CIRCULATIONAHA.121.058615  0.097
2017 Hertenstein A, Chiblak S, Hielscher T, Ciprut S, Lemke D, Thomé C, Kessler T, Abdollahi A, Platten M, Wick W. P08.19 Resistance towards the MDM2 inhibitor idasanutlin is mediated via the NFkB pathway and IGFBP1 upregulation in glioblastoma Neuro-Oncology. 19: iii58-iii58. DOI: 10.1093/NEUONC/NOX036.209  0.095
2012 Platten M, Wick W. Blood-brain barrier and brain edema. Handbook of Clinical Neurology. 104: 53-62. PMID 22230435 DOI: 10.1016/B978-0-444-52138-5.00005-0  0.093
2020 Hoyer C, Grassl N, Bail K, Stein P, Ebert A, Platten M, Szabo K. Changes in Demographic and Diagnostic Spectra of Patients with Neurological Symptoms Presenting to an Emergency Department During the COVID-19 Pandemic: A Retrospective Cohort Study. Neuropsychiatric Disease and Treatment. 16: 2221-2227. PMID 33061392 DOI: 10.2147/NDT.S273913  0.092
2016 Sahm F, Korshunov A, Schrimpf D, Stichel D, Jones DT, Capper D, Koelsche C, Reuss D, Kratz A, Huang K, Wefers AK, Schick M, Bewerunge-Hudler M, Mittelbronn M, Platten M, et al. Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomas. Acta Neuropathologica. PMID 28000032 DOI: 10.1007/S00401-016-1657-7  0.092
2023 Abu Sammour D, Cairns JL, Boskamp T, Marsching C, Kessler T, Ramallo Guevara C, Panitz V, Sadik A, Cordes J, Schmidt S, Mohammed SA, Rittel MF, Friedrich M, Platten M, Wolf I, et al. Spatial probabilistic mapping of metabolite ensembles in mass spectrometry imaging. Nature Communications. 14: 1823. PMID 37005414 DOI: 10.1038/s41467-023-37394-z  0.091
2013 Platten M, Fätkenheuer G. Lersivirine - a new drug for HIV infection therapy. Expert Opinion On Investigational Drugs. 22: 1687-94. PMID 24128277 DOI: 10.1517/13543784.2013.846325  0.09
2020 Lercher A, Popa AM, Viczenczova C, Kosack L, Klavins K, Agerer B, Opitz CA, Lanz TV, Platten M, Bergthaler A. Hepatocyte-intrinsic type I interferon signaling reprograms metabolism and reveals a novel compensatory mechanism of the tryptophan-kynurenine pathway in viral hepatitis. Plos Pathogens. 16: e1008973. PMID 33045014 DOI: 10.1371/journal.ppat.1008973  0.089
2014 Ochs K, Ott M, Rauschenbach KJ, Sahm F, Opitz CA, von Deimling A, Wick W, Platten M. O6.09 * PROSTAGLANDIN E RECEPTOR-4 ACTIVATION REGULATES TRYPTOPHAN METABOLISM IN HUMAN MALIGNANT GLIOMAS Neuro-Oncology. 16: ii14-ii14. DOI: 10.1093/NEUONC/NOU174.50  0.088
2021 Rysz S, Al-Saadi J, Sjöström A, Farm M, Campoccia Jalde F, Plattén M, Eriksson H, Klein M, Vargas-Paris R, Nyrén S, Abdula G, Ouellette R, Granberg T, Jonsson Fagerlund M, Lundberg J. COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system. Nature Communications. 12: 2417. PMID 33893295 DOI: 10.1038/s41467-021-22713-z  0.088
2001 Platten M, Wick W, Wischhusen J, Weller M. N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) suppresses microglial inducible nitric oxide synthase (iNOS) expression and activity induced by interferon-gamma (IFN-gamma). British Journal of Pharmacology. 134: 1279-84. PMID 11704648 DOI: 10.1038/sj.bjp.0704373  0.084
2021 Platten M, Aladellie L. Neisseria meningitidis serogroup W(P1.5-2) sepsis presenting with myopericarditis in an elderly previously healthy male. Idcases. 25: e01238. PMID 34377672 DOI: 10.1016/j.idcr.2021.e01238  0.083
2024 Tanaka A, Cai T, Platten M, Tollinche LE, DeJoy SJ. Anesthetic Management and Neuromonitoring in a Patient with Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency Undergoing Scoliosis Surgery: A Case Report and Review of Literature. Case Reports in Anesthesiology. 2024: 1050279. PMID 38229914 DOI: 10.1155/2024/1050279  0.083
2009 Wick W, Seidel C, Wick A, Platten M. Neurooncology in elderly patients | Neuroonkologie bei älteren patienten Nervenheilkunde. 28: 304-309.  0.082
2003 Platten M, Eitel K, Wischhusen J, Dichgans J, Weller M. Involvement of protein kinase Cdelta and extracellular signal-regulated kinase-2 in the suppression of microglial inducible nitric oxide synthase expression by N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast). Biochemical Pharmacology. 66: 1263-70. PMID 14505805 DOI: 10.1016/S0006-2952(03)00449-0  0.082
2021 Mohapatra SR, Sadik A, Sharma S, Poschet G, Gegner HM, Lanz TV, Lucarelli P, Klingmüller U, Platten M, Heiland I, Opitz CA. Hypoxia Routes Tryptophan Homeostasis Towards Increased Tryptamine Production. Frontiers in Immunology. 12: 590532. PMID 33679737 DOI: 10.3389/fimmu.2021.590532  0.081
2013 Hardie MJ, Thyer IA, Giardina T, Platten MA, Hudson MJ, Drury PJ, Spagnolo D. Diffuse large B cell lymphoma evolving from extranodal marginal zone lymphoma as the first presentation of complicated coeliac disease: Case report and review of the literature Journal of Hematopathology. 6: 33-37. DOI: 10.1007/s12308-011-0126-4  0.081
2021 Platten M, Brusini I, Andersson O, Ouellette R, Piehl F, Wang C, Granberg T. Deep Learning Corpus Callosum Segmentation as a Neurodegenerative Marker in Multiple Sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 33587820 DOI: 10.1111/jon.12838  0.081
2001 Leitlein J, Aulwurm S, Waltereit R, Naumann U, Wagenknecht B, Garten W, Weller M, Platten M. Processing of immunosuppressive pro-TGF-beta 1,2 by human glioblastoma cells involves cytoplasmic and secreted furin-like proteases. Journal of Immunology (Baltimore, Md. : 1950). 166: 7238-43. PMID 11390472 DOI: 10.4049/Jimmunol.166.12.7238  0.08
2014 Redaelli C, Pilz C, Kunze A, Schaekel K, Poschet G, Arnold B, Wick W, Platten M. UV irradiation-mediated systemic immune suppression through AHR signalling Journal of Neuroimmunology. 275: 128-129. DOI: 10.1016/j.jneuroim.2014.08.344  0.08
2014 Bessede A, Gargaro M, Pallotta MT, Matino D, Servillo G, Brunacci C, Bicciato S, Mazza EM, Macchiarulo A, Vacca C, Iannitti R, Tissi L, Volpi C, Belladonna ML, Orabona C, ... ... Platten M, et al. Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature. 511: 184-90. PMID 24930766 DOI: 10.1038/Nature13323  0.079
2019 Hilf N, Kuttruff-Coqui S, Frenzel K, Bukur V, Stevanović S, Gouttefangeas C, Platten M, Tabatabai G, Dutoit V, van der Burg SH, Straten PT, Martinez-Ricarte F, Ponsati B, Okada H, Lassen U, et al. Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma. Nature. PMID 30733620 DOI: 10.1038/S41586-019-0959-Z  0.078
2019 Hoyer C, Stein P, Rausch HW, Alonso A, Nagel S, Platten M, Szabo K. The use of a dedicated neurological triage system improves process times and resource utilization: a prospective observational study from an interdisciplinary emergency department. Neurological Research and Practice. 1: 29. PMID 33324895 DOI: 10.1186/s42466-019-0036-y  0.077
2017 Fatar M, Akin I, Borggrefe M, Platten M, Alonso A. [Interaction between heart and brain in sudden cardiac death]. Herz. PMID 28246702 DOI: 10.1007/s00059-017-4547-4  0.075
2002 MacQuillan GC, de Boer WB, Platten MA, McCaul KA, Reed WD, Jeffrey GP, Allan JE. Intrahepatic MxA and PKR protein expression in chronic hepatitis C virus infection. Journal of Medical Virology. 68: 197-205. PMID 12210408 DOI: 10.1002/jmv.10182  0.073
2020 Hoyer C, Weber L, Sandikci V, Ebert A, Platten M, Szabo K. Decreased admissions and change in arrival mode in patients with cerebrovascular events during the first surge of the COVID-19 pandemic. Neurological Research and Practice. 2: 47. PMID 33225224 DOI: 10.1186/s42466-020-00094-w  0.071
1998 Batchelor TT, Platten M, Palmer-Toy DE, Hunter GJ, Lev MH, Dalmau J, Hochberg FH. Chorea as a paraneoplastic complication of Hodgkin's disease. Journal of Neuro-Oncology. 36: 185-90. PMID 9525818 DOI: 10.1023/A:1005860103173  0.07
1989 Allan GM, McNulty MS, Bryson D, Mackie D, Platten M. Demonstration of bovine virus diarrhoea virus antigen in formalin fixed, paraffin embedded tissue using a streptavidin/biotin technique. Research in Veterinary Science. 46: 416-8. PMID 2544973  0.069
2009 Anders C, Platten M. II Communication - More than logopedics? Art and music therapy in neurological/neurosurgical rehabilitation at the Helios Clinic, Holthausen | II Kommunikation - Mehr als Logopädie? Kunst- und Musiktherapie in der Neurologisch-Neurochirurgischen Rehabilitation der Helios-Klinik Holthausen Neurologie Und Rehabilitation. 15: 51.  0.066
2009 MacQuillan GC, Caterina P, de Boer B, Allan JE, Platten MA, Reed WD, Jeffrey GP. Ultra-structural localisation of hepatocellular PKR protein using immuno-gold labelling in chronic hepatitis C virus disease. Journal of Molecular Histology. 40: 171-6. PMID 19642004 DOI: 10.1007/s10735-009-9227-0  0.065
2018 Hohneck AH, Doesch C, Sandberg R, Lossnitzer D, Rudic B, Tueluemen E, Fatar M, Platten M, Schoenberg SO, Borggrefe M, Papavassiliu T. P4691Presence of late gadolinium enhancement and left atrial ejection fraction as predictors of stroke and thrombembolism in patients with hypertrophic cardiomyopathy - a cardiovascular MRI study European Heart Journal. 39. DOI: 10.1093/EURHEARTJ/EHY563.P4691  0.065
2016 Laible M, Jarius S, Mackensen F, Schmidt-Bacher A, Platten M, Haas J, Albrecht P, Wildemann B. Adding Papillomacular Bundle Measurements to Standard Optical Coherence Tomography Does Not Increase Sensitivity to Detect Prior Optic Neuritis in Patients with Multiple Sclerosis. Plos One. 11: e0155322. PMID 27171375 DOI: 10.1371/journal.pone.0155322  0.065
2005 Platten M, Ho P, Youssef S, Garren H, Fontoura P, Sobel R, Selley M, Steinman L. 3,4-DAA, an orally active synthetic tryptophan catabolite, treats established autoimmune neuroinflammation Aktuelle Neurologie. 32. DOI: 10.1055/s-2005-919610  0.065
2015 Caskey M, Klein F, Lorenzi JC, Seaman MS, West AP, Buckley N, Kremer G, Nogueira L, Braunschweig M, Scheid JF, Horwitz JA, Shimeliovich I, Ben-Avraham S, Witmer-Pack M, Platten M, et al. Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117. Nature. 522: 487-91. PMID 25855300 DOI: 10.1038/Nature14411  0.065
2022 Brusini I, Platten M, Ouellette R, Piehl F, Wang C, Granberg T. Automatic deep learning multicontrast corpus callosum segmentation in multiple sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 35083815 DOI: 10.1111/jon.12972  0.064
1988 Bryson DG, Cush PF, McNulty MS, Platten M, Allan GM. An immunoperoxidase method of detecting respiratory syncytial virus antigens in paraffin sections of pneumonic bovine lung. American Journal of Veterinary Research. 49: 1121-6. PMID 2458691  0.064
1988 Smyth JA, Platten MA, McFerran JB. A study of the pathogenesis of egg drop syndrome in laying hens. Avian Pathology : Journal of the W.V.P.A. 17: 653-66. PMID 18766722 DOI: 10.1080/03079458808436483  0.061
2009 Stewart CJ, Chan T, Platten M. Acquired lymphangiectasia ('lymphangioma circumscriptum') of the vulva: a report of eight cases. Pathology. 41: 448-53. PMID 19396719 DOI: 10.1080/00313020902885052  0.058
2012 Dessauvagie B, Tie B, Peverall J, Baker L, Platten M, Amanuel B. The utility of MDM2 and CDK4 immunohistochemistry in the diagnosis of lipomatous tumours and correlation with fluorescence in situ hybridisation Pathology. 44: S60. DOI: 10.1016/S0031-3025(16)32748-9  0.057
2012 Dessauvagie B, Tie B, Peverall J, Baker L, Platten M, Amanuel B. The utility of MDM2 and CDK4 immunohistochemistry in the diagnosis of lipomatous tumours and correlation with fluorescence in situ Hybridisation Pathology. 44: S52-S53. DOI: 10.1016/S0031-3025(16)32725-8  0.057
2010 MacQuillan GC, de Boer WB, Allan JE, Platten MA, Reed WD, Jeffrey GP. Hepatocellular MxA protein expression supports the differentiation of recurrent hepatitis C disease from acute cellular rejection after liver transplantation. Clinical Transplantation. 24: 252-8. PMID 19712085 DOI: 10.1111/j.1399-0012.2009.01068.x  0.056
2011 Wyen C, Hendra H, Siccardi M, Platten M, Jaeger H, Harrer T, Esser S, Bogner JR, Brockmeyer NH, Bieniek B, Rockstroh J, Hoffmann C, Stoehr A, Michalik C, Dlugay V, et al. Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens. The Journal of Antimicrobial Chemotherapy. 66: 2092-8. PMID 21715435 DOI: 10.1093/jac/dkr272  0.055
2012 Wallace M, Messineo A, Duffy S, Adams L, Jeffrey G, Speers D, de Boer B, Platten M, Cheng W, MacQuillan G. 546 VERY LOW ENDOGENOUS LEVELS OF HEPATOCELLULAR MXA PROTEIN SUGGESTS MINIMAL ACTIVATION OF THE TYPE I INTERFERON PATHWAY IN CHRONIC HBV DISEASE Journal of Hepatology. 56: S216-S217. DOI: 10.1016/S0168-8278(12)60559-5  0.055
2021 Hoyer C, Higashida K, Fabbian F, De Giorgi A, Sandikci V, Ebert A, Platten M, Okazaki S, Manfredini R, Szabo K. Chronobiology of transient global amnesia. Journal of Neurology. PMID 34104990 DOI: 10.1007/s00415-021-10639-x  0.055
2014 Oezen I, Mildenberger I, Platten M. Inhibition of kynurenine 3-monooxygenase in EAE Journal of Neuroimmunology. 275: 127. DOI: 10.1016/j.jneuroim.2014.08.340  0.054
2023 Kapell H, Fazio L, Dyckow J, Schwarz S, Cruz-Herranz A, Mayer C, Campos J, D Este E, Möbius W, Cordano C, Pröbstel AK, Gharagozloo M, Zulji A, Narayanan Naik V, Delank AK, ... ... Platten M, et al. Neuron-oligodendrocyte potassium shuttling at nodes of Ranvier protects against inflammatory demyelination. The Journal of Clinical Investigation. PMID 36719741 DOI: 10.1172/JCI164223  0.054
2011 Lee S, de Boer WB, Fermoyle S, Platten M, Kumarasinghe MP. Human epidermal growth factor receptor 2 testing in gastric carcinoma: issues related to heterogeneity in biopsies and resections. Histopathology. 59: 832-40. PMID 22092394 DOI: 10.1111/j.1365-2559.2011.04017.x  0.054
2022 Sandikci V, Ebert A, Zurwesten L, Platten M, Szabo K, Hoyer C. The remains of the day: neuropsychological findings in postacute transient global amnesia. Journal of Neurology. PMID 35394173 DOI: 10.1007/s00415-022-11110-1  0.053
2021 Sandikci V, Ebert A, Hoyer C, Platten M, Szabo K. Impaired semantic memory during acute transient global amnesia. Journal of Neuropsychology. PMID 34021536 DOI: 10.1111/jnp.12251  0.052
2015 Tykocinski L, Lauffer A, Bohnen A, Krienke S, Tretter T, Adam I, Mohapatra S, Saikali P, Löhning M, Neidhart M, Gay S, Oezen I, Platten M, Opitz C, Lorenz H. A1.28 Synovial fibroblasts suppress TH1, but not TH2 or TH17 cells, through tryptophan metabolism Annals of the Rheumatic Diseases. 74: A12.1-A12. DOI: 10.1136/annrheumdis-2015-207259.28  0.052
2021 Grassl N, Baumann S, Kruska M, Fatar M, Akin I, Platten M, Borggrefe M, Alonso A, Szabo K, Fastner C. [Acute ischemic stroke and elevated troponin: Diagnostic work-up and therapeutic consequences]. Deutsche Medizinische Wochenschrift (1946). PMID 33636737 DOI: 10.1055/a-1308-7490  0.05
2000 Platten M, Wick W, Wild-Bode C, Aulwurm S, Dichgans J, Weller M. Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via Up-regulation of alpha(V)beta(3) integrin expression. Biochemical and Biophysical Research Communications. 268: 607-11. PMID 10679251 DOI: 10.1006/bbrc.2000.2176  0.05
2003 MACQUILLAN G, CATERINA P, BASTIAANDEBOER W, PLATTEN M, REED W, JEFFREY G. 638 Analysis of the involvement of PKR protein in resistance to therapy for chronic hepatitis C virus infection Hepatology. 38: 468-468. DOI: 10.1016/S0270-9139(03)80680-8  0.049
2014 Lanz TV, Becker S, Iwantscheff S, Grabitz C, Böhler L, Wick W, Platten M. Tryptophan-2,3-dioxygenase in experimental autoimmune encephalomyelitis Journal of Neuroimmunology. 275: 65. DOI: 10.1016/j.jneuroim.2014.08.171  0.047
2011 Wong D, Spagnolo D, Bisceglia M, Havlat M, McCallum D, Platten M. 56. Oncocytic adrenocortical neoplasms – a clinicopathological study of 13cases Pathology. 43: S106-S107. DOI: 10.1016/S0031-3025(16)33344-X  0.047
2013 Platten M. Aryl hydrocarbon receptor (AhR) regulation of inflammation and cancer Toxicology Letters. 221: S29. DOI: 10.1016/J.TOXLET.2013.06.103  0.046
2023 Alonso A, Kraus J, Ebert A, Nikolayenko V, Kruska M, Sandikci V, Lesch H, Duerschmied D, Platten M, Baumann S, Szabo K, Akin I, Fastner C. Left atrial area index provides the best prediction of atrial fibrillation in ischemic stroke patients: results from the LAETITIA observational study. Frontiers in Neurology. 14: 1237550. PMID 37854062 DOI: 10.3389/fneur.2023.1237550  0.046
2023 Singh K, Hotchkiss KM, Parney IF, De Groot J, Sahebjam S, Sanai N, Platten M, Galanis E, Lim M, Wen PY, Minniti G, Colman H, Cloughesy TF, Mehta MP, Geurts M, et al. Correcting the drug development paradigm for glioblastoma requires serial tissue sampling. Nature Medicine. PMID 37488293 DOI: 10.1038/s41591-023-02464-8  0.046
2021 Hoyer C, Kahlert C, Güney R, Schlichtenbrede F, Platten M, Szabo K. Central retinal artery occlusion as a neuro-ophthalmological emergency: the need to raise public awareness. European Journal of Neurology. PMID 33452753 DOI: 10.1111/ene.14735  0.045
2008 Platten M. Immunsuppression durch mesenchymale Stammzellen – therapeutische Implikationen für die Multiple Sklerose Aktuelle Neurologie. 35. DOI: 10.1055/s-0028-1086504  0.045
2014 Messineo A, DeBoer B, Platten M, Huang Y, Jeffrey G, MacQuillan G. P209 INCREASED DNA METHYLATION IS OBSERVED IN HCV rs12979860 CC HCV PATIENTS WITH LOW HEPATOCELLULAR MxA PROTEIN LEVELS Journal of Hepatology. 60: S135-S136. DOI: 10.1016/S0168-8278(14)60371-8  0.045
2019 Platten M. How to integrate immunotherapy into standard of care in glioblastoma. Neuro-Oncology. PMID 30938444 DOI: 10.1093/neuonc/noz043  0.044
1991 Bryson DG, Platten MF, McConnell S, McNulty MS. Ultrastructural features of lesions in bronchiolar epithelium in induced respiratory syncytial virus pneumonia of calves. Veterinary Pathology. 28: 293-9. PMID 1949508 DOI: 10.1177/030098589102800405  0.044
2013 Messineo A, Duffy S, Huang Y, Platten M, De Boer B, Jeffrey G, Mac Quillan G. 472 HEPATOCELLULAR MxA PROTEIN EXPRESSION IS A POWERFUL PREDICTOR OF SUSTAINED VIROLOGICAL RESPONSE IN CHRONIC HEPATITIS C GENOTYPE 1 INFECTION USING A MULTIVARIATE LOGISTIC REGRESSION MODEL Journal of Hepatology. 58: S193-S194. DOI: 10.1016/S0168-8278(13)60474-2  0.044
2022 Hoyer C, Winzer S, Matthé E, Heinle I, Sandikci V, Nabavi D, Platten M, Puetz V, Szabo K. Current diagnosis and treatment practice of central retinal artery occlusion: results from a survey among German stroke units. Neurological Research and Practice. 4: 30. PMID 35909171 DOI: 10.1186/s42466-022-00193-w  0.043
2013 Platten MJ, Newman E, Quayle E. Self-esteem and its relationship to mental health and quality of life in adults with cystic fibrosis. Journal of Clinical Psychology in Medical Settings. 20: 392-9. PMID 23264083 DOI: 10.1007/s10880-012-9346-8  0.043
2004 Acton MNF, Platten MF, Wright JR, Cooper JE, Olsson A. Prediction of the non-linear response of a clamped panel to acoustic loading Proceedings of the 2004 International Conference On Noise and Vibration Engineering, Isma. 3671-3685.  0.042
2019 Platten M. Driving mesenchymal transition in glioblastoma. Neuro-Oncology. PMID 31628483 DOI: 10.1093/neuonc/noz195  0.041
2014 Ehren K, Hertenstein C, Kümmerle T, Vehreschild JJ, Fischer J, Gillor D, Wyen C, Lehmann C, Cornely OA, Jung N, Gravemann S, Platten M, Wasmuth JC, Rockstroh JK, Boesecke C, et al. Causes of death in HIV-infected patients from the Cologne-Bonn cohort. Infection. 42: 135-40. PMID 24081925 DOI: 10.1007/s15010-013-0535-7  0.041
2013 Backhouse A, Low I, Sterrett G, Amanuel B, Singh S, Platten M, Kumarasinghe P. 3. Analysis of potential prognostic factors in a unique collection of anaplastic thyroid carcinomas containing a well differentiated component Pathology. 45: S105. DOI: 10.1097/01.PAT.0000427003.13731.48  0.041
2014 Platten M, Linnemann R, Kümmerle T, Jung N, Wyen C, Ehren K, Gravemann S, Gillor D, Cornely OA, Fischer J, Lehmann C, Rockstroh JK, Fätkenheuer G, Vehreschild JJ. Clinical course and quality of care in ART-naïve patients newly presenting in a HIV outpatient clinic. Infection. 42: 849-57. PMID 24965613 DOI: 10.1007/s15010-014-0646-9  0.04
2022 Fastner C, Szabo K, Samartzi M, Kruska M, Akin I, Platten M, Baumann S, Alonso A. Treatment standards for direct oral anticoagulants in patients with acute ischemic stroke and non-valvular atrial fibrillation: A survey among German stroke units. Plos One. 17: e0264122. PMID 35176109 DOI: 10.1371/journal.pone.0264122  0.04
2022 Grassl N, Ebert AD, Szabo K, Aghazadeh Y, Platten M, Alonso A. Pearls And Oy-Sters: Hemiballism and Orbitofrontal-Like Syndrome in a Patient With Unilateral Tuberothalamic Stroke. Neurology. PMID 35918157 DOI: 10.1212/WNL.0000000000201066  0.039
2013 Fätkenheuer G, Gillor D, Platten M, Kochanek M, Salzberger B. Aerosolized ribavirin for patients with cancer and respiratory syncytial virus infection. The Journal of Infectious Diseases. 207: 1621. PMID 23444009 DOI: 10.1093/infdis/jit071  0.038
2004 Platten MF, Wright JR, Cooper JE. Identification of a continuous structure with discrete non-linear components using an extended modal model Proceedings of the 2004 International Conference On Noise and Vibration Engineering, Isma. 2155-2168.  0.038
2022 Hoyer C, Schlenker J, Sandikci V, Ebert A, Wittayer M, Platten M, Szabo K. Sex-Specific Differences in Pre-Stroke Characteristics Reveal Vulnerability of Elderly Women. Journal of Personalized Medicine. 12. PMID 35330344 DOI: 10.3390/jpm12030344  0.037
2009 Platten MF, Wright JR, Dimitriadis G, Cooper JE. Identification of multi-degree of freedom non-linear systems using an extended modal space model Mechanical Systems and Signal Processing. 23: 8-29. DOI: 10.1016/j.ymssp.2007.11.016  0.037
2007 Pears J, Smith A, Platten M, Abe T, Wilson B, Cheng Y, Felice M. Predicting variation in the NVH characteristics of an automatic transmission using a detailed parametric modelling approach Sae Technical Papers. DOI: 10.4271/2007-01-2234  0.036
2004 Naylor S, Platten MF, Wright JR, Cooper JE. Identification of multi-degree of freedom systems with nonproportional damping using the resonant decay method Journal of Vibration and Acoustics, Transactions of the Asme. 126: 298-306. DOI: 10.1115/1.1687395  0.035
2004 Platten MF, Wright JR, Cooper JE. Identification of a simulated continuous structure with discrete non-linear components using an extended modal model Proceedings of the 7th Biennial Conference On Engineering Systems Design and Analysis, Esda 2004. 2: 229-236.  0.035
2005 Platten MF, Wright JR, Worden K, Cooper JE, Dimitriadis G. Non-linear identification using a genetic algorithm approach for model selection Conference Proceedings of the Society For Experimental Mechanics Series.  0.033
2004 Platten M, Jüptner U. Praxistaugliche Alternative zur Voranodisation Jot, Journal Fuer Oberflaechentechnik. 44: 72-76.  0.031
2021 Hoyer C, Ebert A, Sandikci V, Platten M, Szabo K. Sex-related differences in stressful events precipitating transient global amnesia - A retrospective observational study. Journal of the Neurological Sciences. 425: 117464. PMID 33892277 DOI: 10.1016/j.jns.2021.117464  0.029
2009 Seidel C, Platten M, Wick W. Akuter generalisierter Myoklonus nach Einnahme von Citalopram Aktuelle Neurologie. 36. DOI: 10.1055/S-0029-1238682  0.029
2009 Platten MF, Wright JR, Cooper JE, Dimitriadis G. Identification of a nonlinear wing structure using an extended modal model Journal of Aircraft. 46: 1614-1626. DOI: 10.2514/1.42024  0.026
2000 Wright JR, Platten MF, Cooper JE, Sarmast M. Identification of non-linear multi-degree of freedom systems using a force appropriation approach Proceedings of the 25th International Conference On Noise and Vibration Engineering, Isma. 461-464.  0.025
1995 Nelson RT, McLoughlin MF, Rowley HM, Platten MA, McCormick JI. Isolation of a toga-like virus from farmed Atlantic salmon Salmo salar with pancreas disease Diseases of Aquatic Organisms. 22: 25-32.  0.022
2002 Platten MF, Wright JR, Cooper JE, Sarmast M. Identification of multi-degree of freedom non-linear simulated and experimental systems Proceedings of the 2002 International Conference On Noise and Vibration Engineering, Isma. 1195-1202.  0.022
2009 Hickey D, Worden K, Platten MF, Wright JR, Cooper JE. Higher-order spectra for identification of nonlinear modal coupling Mechanical Systems and Signal Processing. 23: 1037-1061. DOI: 10.1016/j.ymssp.2008.10.008  0.021
2006 Hickey D, Worden K, Platten MF, Wright JR, Cooper JE. Bispectral analysis of a Wing-Pylon model in order to identify nonlinear coupling Conference Proceedings of the Society For Experimental Mechanics Series.  0.021
1977 Platten MC. Points from Letters: Value of home visiting Bmj. 1: 908-908. DOI: 10.1136/BMJ.1.6065.908-E  0.021
2002 Platten MF, Wright JR, Cooper JE, Sarmast M. Identification of multi-degree of freedom non-linear systems using an extension of force appropriation Proceedings of Spie - the International Society For Optical Engineering. 4753: 957-963.  0.02
2005 Battaglia MA, Dodson JM, Shepperd WD, Platten MJ, Tallmadge OM. Colorado front range fuel photo series Usda Forest Service - General Technical Report Rmrs-Gtr.  0.018
2018 Platten M. Ergebnisse einmal mehr überinterpretiert Info Neurologie & Psychiatrie. 20: 19-19. DOI: 10.1007/s15005-018-2678-7  0.018
2014 Platten M, Pham HN, Nguyen HV, Nguyen NT, Le GM. Knowledge of HIV and factors associated with attitudes towards HIV among final-year medical students at Hanoi medical university in Vietnam. Bmc Public Health. 14: 265. PMID 24649918 DOI: 10.1186/1471-2458-14-265  0.017
2002 Platten MF, Wright JR, Cooper JE. The use of a non-contact acoustic excitation array for the estimation of damping in aircraft panels Proceedings of the 2002 International Conference On Noise and Vibration Engineering, Isma. 451-460.  0.016
2013 Togai K, Platten M. Input torque shaping for driveline NVH improvement and torque profile approximation problem with combustion pressure Lecture Notes in Electrical Engineering. 201: 151-165. DOI: 10.1007/978-3-642-33832-8_12  0.016
2007 Smith A, Pears J, Platten M, Palmer D, Hirabayashi Y. Epicyclic gear transmission error - The importance of controlling tolerances Sae Technical Papers. DOI: 10.4271/2007-01-2241  0.015
1994 Platten M, McLoughlin M, Shinn AP. Distribution and identification of gyrodactylid species in fish farms and rivers of Northern Ireland. The Veterinary Record. 135: 411-2. PMID 7856035  0.012
2017 Platten M, Kisten Y, Kälvesten J, Arnaud L, Forslind K, van Vollenhoven R. Fully automated joint space width measurement and digital X-ray radiogrammetry in early RA. Rmd Open. 3: e000369. PMID 28879043 DOI: 10.1136/rmdopen-2016-000369  0.012
2009 Platten M, Blockley C, James B, Prabahakaran S, Scott D. Optimization of gear microgeometry for durability and nvh Sound and Vibration. 43: 7-10.  0.011
2022 Kebir S, Lazaridis L, Wick W, Platten M, Tabatabai G, Combs SE, Schmidt T, Agkatsev S, Blau T, Mäurer I, Kahlert U, Sagerer A, Berberich A, Heider S, Müther M, et al. Gender disparity regarding work-life balance satisfaction among German neuro-oncologists: a YoungNOA survey. Neuro-Oncology. PMID 35639965 DOI: 10.1093/neuonc/noac114  0.01
2018 Platten M. Rekombinante Viren zur Glioblastomtherapie Info Onkologie. 21: 18-18. DOI: 10.1007/s15004-018-6265-3  0.01
2013 Wick W, Platten M. Moderne Therapiestrategien bei hirneigenen glialen Tumoren Info Neurologie & Psychiatrie. 15: 38-51. DOI: 10.1007/s15005-013-0305-1  0.01
2013 Wick W, Platten M. Moderne Therapiestrategien bei hirneigenen glialen Tumoren Info Onkologie. 16: 32-43. DOI: 10.1007/s15004-013-0549-4  0.01
2011 Redley M, Clare ICH, Dunn MC, Platten M, Holland AJ. Introducing the mental capacity advocate (IMCA) service and the reform of adult safeguarding procedures British Journal of Social Work. 41: 1058-1069. DOI: 10.1093/bjsw/bcr003  0.01
1988 Barker BO, Platten MR. Student Perceptions on the Effectiveness of College Credit Courses Taught via Satellite American Journal of Distance Education. 2: 44-50. DOI: 10.1080/08923648809526623  0.01
1983 Platten M. Doctors one, priests one Bmj. 286: 1652-1652. DOI: 10.1136/BMJ.286.6378.1652  0.01
Hide low-probability matches.